Skip to main content
Journal of Cardiovascular Magnetic Resonance logoLink to Journal of Cardiovascular Magnetic Resonance
. 2023 Dec 23;26(1):100007. doi: 10.1016/j.jocmr.2023.100007

Society for Cardiovascular Magnetic Resonance 2022 Cases of SCMR case series

Jason N Johnson a, Hamidreza Pouraliakbar b, Mohammad Mahdavi b, Abdolmohammad Ranjbar b,c, Kristopher Pfirman d, Vishal Mehra d, Shahzad Ahmed d, Wejdan Ba-Atiyah e, Mohammed Omar Galal e, Riad Abou Zahr e, Nasir Hussain f, Raghu R Tadikamalla g, Victor Farah f, Sanja Dzelebdzic h, Juan Carlos Muniz h, Marc Lee i, Jason Williams i, Simon Lee i, Sachin K Aggarwal j, Daniel E Clark k, Sean G Hughes k, Madhusudan Ganigara l, Mohamed Nagiub m, Tarique Hussain n, Cecilia Kwok o, Han S Lim p, Mark Nolan o,q, Daniel S Kikuchi r, Clive A Goulbourne s, Anurag Sahu s, Berge Sievers t, Berk Sievers t, Burkhard Sievers u, Rimmy Garg v, Carlos Requena Armas v, Vijayasree Paleru v, Ritu Agarwal w, Rengarajan Rajagopal x, Pranav Bhagirath y, Rebecca Kozor z, Ashish Aneja aa, Robert Tunks ab, Sylvia SM Chen ac,
PMCID: PMC11211240  PMID: 38211509

Abstract

“Cases of SCMR” is a case series on the SCMR website (https://www.scmr.org) for the purpose of education. The cases reflect the clinical presentation, and the use of cardiovascular magnetic resonance (CMR) in the diagnosis and management of cardiovascular disease. The 2022 digital collection of cases are presented in this manuscript.

Keywords: COVID-19, Coronary artery aneurysm, Cardio-oncology, Metastatic disease, Congenital Heart disease, Myocarditis, Vaccine associated myocarditis, Myocardial. infarction, Viability, Arrhythmogenic cardiomyopathy, Hypertrophic cardiomyopathy, Takotsubo, Hydatid disease

1. Introduction

It is a pleasure to present the Cases of Society for Cardiovascular Magnetic Resonance 2022 case series. Thank you to our fabulous team of Associate Editors and Reviewers for bringing such commitment, enthusiasm, and valuable experience and knowledge to Cases of SCMR. The United States, Europe, Australia, Asia and the Middle East contributed to the 2022 cases. These showcased pediatric and adult congenital heart disease (CHD), cardiomyopathies, cardiac masses, coronary anomalies and disease, and the impact of coronavirus disease 2019 (COVID-19) infection and vaccination. All cases demonstrated the importance of cardiovascular magnetic resonance (CMR) in assessing and diagnosing cardiovascular disease, and thus providing essential information for clinical management. Please enjoy these cases, and we look forward to more new and exciting cases in the future. Please submit to https://scmr.org/page/SubmitCase. Cases that demonstrate the utility of CMR and its complimentary role to other imaging modalities are appropriate for submission [1], [2], [3].

2. Case 1: An infant with giant coronary artery aneurysm due to multisystem inflammatory syndrome following COVID-19

2.1. Clinical history

An eight-month-old boy with a history of recent COVID-19 infection (with positive real-time polymerase chain reaction (PCR) test one month before presentation) was referred with symptoms of tachycardia, poor feeding, and respiratory distress. His symptoms for COVID-19 infection (one month before presentation) were mild fever, conjunctivitis, restlessness. Two other family members also tested positive for COVID-19. Conservative treatment had been considered due to his mild to moderate symptoms. Physical examination revealed fever (39 °C lasting more than 72 hours), faint friction rub, tachycardia, respiratory distress, and conjunctivitis as well as symptoms of gastroenteritis including mild diarrhea and abdominal pain. Laboratory data included an elevated C-reactive protein (80 mg/L; normal < 9 mg/L), elevated erythrocyte sedimentation rate (90 mm/hr; normal < 10 mm/hr), serum procalcitonin level of 1.25 ng/dl (normal <5 ng/dl), D-dimer of 2.56 ng/dl (normal < 50000 ng/dl), lactate dehydrogenase (LDH) level of 1700 U/L (normal 200 U/L), leukocytosis with 16.7 k/dl white blood cells (normal < 1.1 k/dl) and 900 lymphocyte count (normal 850 – 4800), and elevated cardiac troponin I level (2.13 ng/dL; normal range <0.03 ng/dL). The patient was treated for a diagnosis of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 with prednisolone, intravenous immune globulin (IVIG), and aspirin. Transthoracic echocardiography (TTE) demonstrated a large pericardial effusion with evidence of tamponade by early diastolic right ventricular (RV) and right atrial (RA) collapse and septal bounce, and moderately reduced left ventricular (LV) systolic function (LV ejection fraction (LVEF) = 40%). After percutaneous pericardiocentesis, the patients’ symptoms alleviated and CMR was performed.

2.2. CMR findings

CMR was performed at 1.5 T (Avanto, Siemens Healthineers AG, Erlangen, Germany). Cine images revealed mild pericardial effusion and a giant aneurysm in the proximal segment of the left anterior descending artery (LAD) (Additional Movie Files 1 and 2). Using T2-weighted imaging, myocardial edema was also depicted (Fig. 1). Possible mid to epicardial late gadolinium enhancement (LGE) in the basal anterior and inferolateral wall was evident (Fig. 2).

Fig. 1.

Fig. 1

Case 1. Fig. 1. T2-weighted (T2w) double inversion recovery four chamber view. There is evidence of myocardial edema in the lateral left ventricular (LV) wall.

Fig. 2.

Fig. 2

Case 1. Fig. 2. Short axis stack (A-C) and four (D), three (E), two (F) chamber late gadolinium enhancement (LGE) imaging. Possible mid to epicardial hyperenhancement is seen in the basal anterior and inferolateral wall was evident.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 1, Movie 2..

Movie 1

Case 1 Movie 1. Balanced steady-state free precession (bSSFP) cine coronal plane. A large aneurysm of LAD (green arrow) coronary artery next to the pulmonary artery is present. The giant aneurysm of the LAD has a comparable diameter to adjacent pulmonary artery.

Download video file (64.3KB, mp4)
Movie 2

Case 1 Movie 2. Short axis bSSFP cine at the base. The giant aneurysm of the LAD can be seen in the interventricular groove (red arrow).

Download video file (65.1KB, mp4)

2.3. Conclusion

Based on the ward policy to visualize possible clots within the coronary aneurysm and any potential congenital anomalies, the pediatric cardiologists obtained a computed tomography (CT) angiogram (CTA), confirming the aneurysmal dilation of the left main coronary artery (5 mm diameter), and multiple fusiform aneurysms with giant aneurysm at proximal portion (10 mm diameter) were depicted in the LAD (Fig. 3). Moreover, multiple fusiform aneurysms along the left circumflex coronary artery (LCx) (6.3 mm diameter) and fusiform dilation of origin of the right coronary artery (RCA; 3.7 mm diameter) were depicted (Additional Movie File 3).

Fig. 3.

Fig. 3

Case 1. Fig. 3. Axial contrast-enhanced cardiac computed tomography (CT) angiography (CTA). Aneurysmal dilation of the left main coronary artery at 5 mm diameter, and multiple fusiform aneurysms in the left anterior descending (LAD) coronary artery with a giant aneurysm (10 mm diameter) at the proximal portion were depicted.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 3..

Movie 3

Case 1 Movie 3. Shaded surface display volume rendering creating a 3D visual illustration of CT volumetric data of the heart. Multiple fusiform aneurysms of coronary arteries are depicted.

Download video file (1.5MB, mp4)

Giant and widespread coronary artery aneurysms in an infant following COVID-19 infection are rarely reported in the literature; however, considering the possibility of fatal consequences, due regard should be given to this phenomenon. Moreover, previously, coronary artery aneurysms were depicted with coronary CMR angiography (CCMRA), nevertheless, in this case, giant coronary artery aneurysms were detected in CMR cine balanced steady state free precession (bSSFP) images. Subsequently treatment with infliximab, heparin, and warfarin was added to the patient’s treatment regime due to the coronary artery involvement, resulting in partial response over two months, and the patient continues to be followed up.

2.4. Perspective

Although COVID-19 is demonstrated to be less severe in children compared to adults, the reports of some devastating and fatal complications following COVID-19 in children and adolescents have generated considerable concern and the number of such reports is rapidly increasing [4]. Kawasaki disease (mucocutaneous lymph node syndrome) is characterized as the most common cause of coronary artery aneurysms in children [5], [6], [7]. Several studies have reported a Kawasaki-like illness following COVID-19 called MIS-C [8], [9], [10]. Although it is similar to Kawasaki disease and toxic shock syndrome, it does not have all features to fulfill the criteria of Kawasaki disease according to the American Heart Association (AHA) Kawasaki guideline (fever plus four of five criteria) [8].

The full spectrum of MIS-C is not clearly described yet but severe forms of the disease can lead to multiple organ failures including neurologic involvement and cardiogenic or vasoplegic shock [11]. Coronary artery dilation and aneurysm formation are reported in 14 - 48% of patients with MIS-C[12], [13], [14].

In the presented case the vasculitis and inflammatory symptoms of the patient overlapped with those of COVID-19, leading to late diagnosis and treatment initiation and subsequently widespread aneurysm formation in the coronary arteries. Two recent studies using CMR imaging in adult patients after recovering from COVID-19 have reported cardiovascular abnormalities in 56 to 78% of middle-aged adults [15]. In another similar study, 15% of college athletes developed cardiovascular abnormalities in CMR imaging. In contrast, cohort studies on children using CMR for follow-up of the patients revealed fewer complications. Webster et al. reported no significant cardiac disease by CMR in a small pediatric cohort of patients at least one month after recovering from acute symptomatic COVID-19 infection or MIS-C [16]. In another study after midterm follow-up (median of 7 months) in 16 children no patients had LGE in CMR imaging [17]. Blondiaux et al. reported diffuse myocardial edema on T2 short tau inversion recovery (STIR) sequences and native T1 mapping in four children after MIS-C, with no evidence of LGE [18].

Evidence is still scarce but rapidly emerging in the literature about the importance of performing CMR in patients with MIS-C. CMR can be considered as a safe and radiation-free imaging modality for evaluation of these patients – in particular the infants and children- and to identify myocarditis as well as functional abnormalities, myocardial ischemia and myocardial infarction (MI) [19]. CMR which is the mainstay in the diagnosis of suspected myocarditis helped us detect the myocarditis in our patient that would be missed if the workups were performed using other routine diagnostic modalities. Our case demonstrated the feasibility of detection of coronary artery aneurysm in CMR cine bSSFP images, especially those with larger sizes. Therefore, due regard should be given to the existence of possible coronary artery aneurysms upon evaluation of cine bSSFP images. Moreover, CCMRA can also be considered for the determination of the origin and course of coronary arteries in case of suspected coronary artery disorders in children. Several studies advocate the accuracy of CCMRA for the detection of coronary artery aneurysms in patients with Kawasaki disease[20], [21]. This technique can be regarded in such cases as a non-invasive and radiation-free imaging alternative when TTE image quality is insufficient, subsequently reducing the need for serial x-ray coronary angiography.

The CMR of Case 1 (Additional File CMR Link, https://www.cloudcmr.com/8757–1973-2018–0101/).

3. Case 2: A case of metastatic choroid malignant melanoma

3.1. Clinical history

A 63-year-old male with a known past medical history of left choroid melanoma presented with increasing dyspnea, hypertension, hyperlipidemia, ongoing tobacco use, and progressive 30-pound weight loss and associated anorexia. Lab work was obtained indicating hyponatremia with a sodium of 128 mg/dL (normal 136–145 mg/dL), elevated LDH of 293 (normal < 250 U/L), and a leukocytosis of 21,300 k/uL (normal < 11,000 k/uL). A chest CT obtained two months prior to presentation identified numerous diffuse nodules throughout the lung fields with associated mediastinal and hilar lymphadenopathy (Fig. 4). A TTE showed a large (1.9 by 1.6 cm) echogenic mass in the LV attached to the anterior septal wall (Fig. 5). A second mass was located in the RV, but difficult to completely visualize (Fig. 5). CMR was requested to better define and characterize the masses.

Fig. 4.

Fig. 4

Case 2. Fig. 1. Chest CT without contrast in the axial plane. There are multiple lung masses present.

Fig. 5.

Fig. 5

Case 2. Fig. 2. Transthoracic echocardiogram (TTE) apical three chamber view (A,B), parasternal short axis (C), and a modified parasternal short axis with contrast enhancement (D). There is a large mass attached to the interventricular septum.

3.2. CMR findings

CMR performed at 1.5 T (Sola, Siemens Healthineers AG, Erlangen, Germany) demonstrated multiple intramyocardial masses in the interatrial septum, RA, LV, and RV; the largest mass measuring 16.5×13 mm in the lateral LV wall (Additional Movie File 4). An anterior mass bulges into the LV cavity and an additional mass is protruding into the RV outflow tract (RVOT) from the anterior septum. These heterogeneous, bulky, masses are hyperintense on cine bSSFP as well as T2 and T1 black blood imaging (Fig. 6). They were highly vascular on first pass rest perfusion (Additional Movie File 5 Case 2 Movie 2) and had profound enhancement on LGE imaging (Fig. 7), extending into the subendocardial and subepicardial layers. The appearance, however, was felt likely due to the native T1 times being significantly shortened by the presence of melanin, rather than profound uptake of gadolinium within the tumors. This same phenomenon can also be seen with mitral annular calcification with caseous necrosis with short native T1 times. Similar masses were also noted along the pericardium, as well as innumerably disseminated throughout the lung fields that have the same tissue characterization as the myocardial metastases. Mediastinal and hilar lymphadenopathy was also present. A low native T1 time of approximately 700ms was observed (Fig. 8). A moderate sized (5–10 mm) circumferential pericardial effusion was present. Real-time, free breathing sequences were utilized when possible due to the patient’s dyspnea and inability to adequately perform breath holds.

Fig. 6.

Fig. 6

Case 2. Fig. 3. T1 weighted (T1w; A,B) and T2w (C,D) spectral adiabatic inversion recovery (SPAIR) images in mid short axis (A,C) and four chamber (B,D) views. Multiple hyperlucent masses in the LV and right ventricle (RV) on both T1 and T2 weighted images are present.

Fig. 7.

Fig. 7

Case 2. Fig. 4. LGE in the basal short axis (A), two chamber (B), and four chamber (C) views. Multiple myocardial masses (arrows) with hyperenhancement are present.

Fig. 8.

Fig. 8

Case 2. Fig. 5. Native T1 (A) and T2 (B) parametric mapping images from the mid short axis view. The measured T1 times of the myocardial masses (arrow) are low and T2 mapping times are variable with the yellow arrow at 52 msec and red arrow at 75 msec.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 4, Movie 5..

Movie 4

Case 2 Movie 1. Cine bSSFP short axis stack. There are multiple intramyocardial masses in the LV and RVs.

Download video file (142.7KB, mp4)
Movie 5

Case 2 Movie 2. Four chamber (A) and mid short axis (B) rest perfusion imaging. There is brisk uptake of contrast of the myocardial masses on first pass perfusion.

Download video file (498.9KB, mp4)

3.3. Conclusion

CMR findings were consistent with an underlying malignant process suggestive of a metastatic disease from the known prior primary left choroid melanoma. The presence of highly-melanin rich metastatic tumors affects T1 relaxation times. T1 relaxation times shorten and recover their signal faster than the surrounding normal myocardium that results in high signal on T1-weighted fast spin echo sequences. This is a quintessential finding that helps differentiate malignant melanoma from other metastatic cardiac tumors. T2-weighted images in this case also exhibited high signal which may or may not be elevated and is also dependent on the amount of surrounding edema. The T1 shortening effects of melanin dominate over the T1 prolongating effects of myocardial inflammation and edema. Malignant melanoma is unique in that it is one of the times where native T1 and T2 times are discordant despite the evidence of edema and necrosis. Given the highly vascularized nature of these tumors, the first pass perfusion is usually preserved, and appears as bright as normal myocardium due to high vascularity. A pericardial effusion is also present in most cases and traditionally exhibits hemorrhagic features. These complex features of the fluid consist of intermediate T2-weighted (T2w) signal intensity and high T1-weighted (T1w) signal intensity. The bSSFP cine images may identify loculations including fibrin strands and thrombi from the dissemination and seeding of the pericardium.

A suspicion of metastatic malignant melanoma was raised from the initial work-up given the findings on the chest CT scan and TTE. Given persistence of the patient’s symptoms in the setting of concerning findings on CMR suggesting disseminated malignant melanoma, he was admitted to the hospital for further management by hematology/oncology to initiate immunotherapy.

Based on CMR findings, a full body fluorodeoxyglucose (FDG) positron emission tomography (PET) CT imaging was performed confirming widespread metastatic disease including the central nervous system. The diagnosis of metastatic malignant melanoma was made and further management with nivolumab, ipilimumab, and allopurinol was implemented. The patient was discharged from the hospital and has elected to continue treatment as an outpatient.

3.4. Perspective

CMR tissue characterization is beneficial when identifying the etiology of myocardial masses. The dimensions, morphology, location and any associated hemodynamic or mass effect, mobility, vascularity, infiltration patterns, magnetic properties, and the presence of associated sequelae such as effusions can help with differentiating the underlying etiology of cardiac masses. The size of benign tumors rarely surpasses 5 cm [22]. Malignant tumors are more likely to infiltrate into the adjacent structures, extend with irregular borders, and demonstrate associated pericardial effusions [23]. The native magnetic properties of tumors as well as the effects of LGE can aid in non-invasive tissue characterization. All malignant tumors are likely to exhibit LGE and first pass resting perfusion imaging due to their vascularity can aid in differentiating malignancy from cardiac thrombi. Prolonged inversion times of greater than or equal to 422 msec have been shown to aid in the delineation of cardiac thrombi from masses on LGE imaging sequences [22]. When all the above is taken into account, diagnostic accuracy has been as high as 92 to nearly 100% in prior studies published [23].

Metastatic melanoma represents approximately 28% of metastatic malignancies involving the heart; most commonly the RA. This equates to an incidence of about 1–5% [22]. CMR has a pivotal role in the differential diagnosis of melanoma from the other disseminated malignancies given the melanin-rich characteristics of the tumors. These tumors are thought to be spread by hematogenous dissemination in most cases [24]. This results in multiple organ system involvement as seen in our case with the central nervous, pulmonary, lymphatic, and cardiac systems inundated with tumor burden.

The unusual pattern of melanoma and significantly reduced T1 relaxation times resulting in enhanced signal intensity is a hallmark feature differentiating it from other cardiac masses. Although rare, the survival rates are dismal with a 5-year survival rate of 15–20% although the rate of mortality is falling from of all malignant melanomas by 5.7%, annually [25]. The overall mean survival rate for stage 4 malignant melanoma was 9.2 months with a median survival of 6.3 months [26]. CMR aids in the diagnosis of malignant melanoma, and relevant implications on patients’ management, but unfortunately given the increased mortality risk associated with this disease, our patient’s overall prognosis is poor.

The CMR of Case 2 can be found here: https://www.cloudcmr.com/4857–1973-8858–0125/).

4. Case 3: Unguarded mitral orifice with double outlet right ventricle and normally related great arteries: CMR diagnosis (winner of ‘Cases of SCMR’s best case of 2022′)

4.1. Clinical history

This is a case of a 4-month-old girl, product of full term pregnancy and birth weight of 2 kg who was postnatally admitted to the neonatal intensive care unit for 25 days at a remote community hospital. She was subsequently discharged home in stable condition. At 3 months of age, she was referred to our center as a case of CHD.

Upon initial outpatient encounter, the patient’s weight was 2.5 kg with oxygen saturation of 90% in room air. On physical examination, she had subtle dysmorphic features with triangular face, hypertelorism, truncal hypotonia, weak cry and depressed deep tendon reflexes. She had mild tachypnea, a soft systolic ejection murmur at the left upper sternal border and the liver was felt 1 cm below the right costal margin. Her systemic examination was otherwise unremarkable. Electrocardiogram (ECG) revealed sinus rhythm and left axis deviation. Chest X-ray showed enlarged cardiac silhouette with mild central vascular congestion (Fig. 9).

Fig. 9.

Fig. 9

Case 3. Fig. 1. Chest x-ray anteroposterior projection. There is cardiomegaly with mild central vascular congestion.

TTE demonstrated situs solitus, levocardia, d-looped ventricles, double outlet right ventricle (DORV) with normally related great arteries, large primum atrial septal defect (ASD), small secundum ASD, and a moderate ventricular septal defect (VSD). Optimal interrogation of the VSD was technically challenging. The LV was suspected to be hypoplastic with mitral atresia and concern for a huge left atrial (LA) appendage (LAA) aneurysm with to and from flow associated with that structure (Fig. 10, Fig. 11, Additional Movie File 6).

Fig. 10.

Fig. 10

Case 3. Fig. 2. TTE parasternal short axis (A), subcostal sagittal (B), and apical four chamber (C,D) views. The RV is anterior to the presumed hypoplastic LV, and a large posterior aneurysm is present. There is flow into the presumed left atrial (LA) appendage aneurysm and presumed hypoplastic LV and mitral atresia (MA).

Fig. 11.

Fig. 11

Case 3. Fig. 3. TTE apical five chamber view in 2D (A) and color Doppler (B) and subcostal oblique view in 2D (C) and color Doppler (D). The aorta (Ao) arises from the RV. The pulmonary valve (PV) arises from the RV as well.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 6..

Movie 6

Case 3 Movie 1. Apical five chamber TTE view. There is a large, thin-walled, hypocontractile left sided chamber, concerning for a possible giant LA appendage aneurysm.

Download video file (1.1MB, mp4)

Understanding the patient's diagnosis and hemodynamics was challenging given the atypical left heart findings. For better evaluation of the “aneurysm” a CMR was performed under general anesthesia.

4.2. CMR findings

The study was performed on a 1.5 T CMR system (Avanto, Siemens Healthineers AG, Erlangen, Germany) with the patient's heart rate ranging from 91–100 beats per minute (bpm). Cine bSSFP imaging demonstrated viscero-atrial situs solitus, d-looped ventricles, DORV with normally related great arteries, small (4 mm) outlet VSD and left superior vena cava to an unroofed coronary sinus. Both atria were enlarged with a large primum ASD. The left atrioventricular (AV) junction was patent with dephasing artifacts across but absent mitral valve apparatus including leaflets, chordae and papillary muscles (Additional Movie File 7). The LAA appeared normal.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 7..

Movie 7

Case 3 Movie 2. Cine bSSFP four chamber view. There is a widely patent left atrioventricular junction with dephasing flow artifact present with absent mitral valve leaflets, chordae and papillary muscles.

Download video file (22.9KB, mp4)

Phase contrast cine imaging demonstrated to-and-fro flow across the mitral annulus with transmitral E/A waveform reversal suggestive of diastolic dysfunction (Fig. 12). There was a net left to right shunt (Qp:Qs =2.4).

Fig. 12.

Fig. 12

Case 3. Fig. 4. Flow versus time of the mitral valve annulus inflow (A), gradient echo of the mitral valve annulus en face (B) with corresponding phases contrast (C) image. There is an E and A wave during mitral valve inflow in diastole with flow reversal during systole.

The RV was significantly dilated (RV end-diastolic volume (RVEDV) indexed (RVEDVI) = 126 mL/m2; Z score + 11) with preserved global systolic function (RV ejection fraction (RVEF) 56%) and mild tricuspid regurgitation [27]. The LV was severely dilated (LV end-diastolic volume (LVEDV) indexed (LVEDVI) = 173.5 mL/m2; Z score + 16) with extremely thin anterior, inferior and lateral walls with moderately depressed global systolic function (LVEF 43%; normal 56–70%)) (Additional Move File 8).

The LV anteroseptal and inferoseptal segments had usual thickness and the basal anteroseptal segment connected to the outlet VSD. Following administration of gadolinium contrast, free breathing single shot LGE imaging from an axial projection demonstrated transmural hyperenhancement in the lateral LV wall suggestive of diffuse fibrosis (Fig. 13).

Fig. 13.

Fig. 13

Case 3. Fig. 5. Four chamber LGE view. Myocardial fibrosis (arrows) in the lateral wall of the LV.

4.3. Conclusion

CMR findings of patent left AV junction, absent mitral valve apparatus, severely dilated, fibrosed, thin-walled LV in the setting of DORV are consistent with a diagnosis of unguarded mitral orifice (UMO).

4.4. Perspective

UMO is an exceedingly rare congenital cardiac anomaly characterized by absence of mitral valve leaflets, chordae and papillary muscles at the mitral annulus with severe thinning of the LV free wall [28], [29]. Being devoid of any mitral tissue leads to unrestricted to-and-fro flow across the left AV junction.

The etiology of UMO remains unclear. Embryologically, development of the mitral valve takes place between the fourth and fifth weeks of gestation. Mitral leaflets, chordae tendineae and papillary muscles form by undermining of the endomyocardial aspect of the LV inlet which occurs along with immersion of the AV sulcus [30]. Yasukochi et al. hypothesized that anomalies in undermining of the endomyocardial aspect of the LV may occur either by maldevelopment or apoptosis prior to leaflets separation from the ventricular myocardium [28]. This can lead to failure of delamination of valvular leaflets and thinning of ventricular wall, the end point of which is UMO with absence of the LV parietal myocardial layer. Another hypothesis by Howley et al. proposed that a defect in normal mitral valve development may result in valve deformity leading to early development of mitral valve incompetence that could alter normal LV development resulting in thinning and dilation [31].

The few reported cases of UMO in the literature are summarized in Table 1 Case 3 [28], [29], [30], [31], [32], [33], [34], [35], [36], [37]. Six cases had DORV and pulmonary atresia/stenosis, one DORV and interrupted aortic arch, one transposition and pulmonary atresia, one AV / ventriculoarterial (VA) concordance with hypoplastic left heart syndrome (HLHS) and aortic atresia, and one with AV / VA concordance and aortic atresia. Seven of eleven cases did not survive, two with unknown outcome and 2 underwent single ventricle pathway. All reported patients were diagnosed postnatally by TTE except one diagnosed prenatally by fetal echocardiogram.

Table 1.

Case 3. Summary of published cases of unguarded mitral orifice.

Author (reference) Year of case report Age at diagnosis Initial presentation Cardiac Diagnosis Management Outcome
Johnson JN et al. 2023 3 months Respiratory distress AV concordant, DORV, normally related great arteries, no aortic/pulmonary stenosis Comfort care Died at 4 months
Howley et. al. [31] 2021 Diagnosed prenatally Respiratory distress, cyanosis and acidosis directly after birth.
Atrial flutter
Concordant AV and VA connections with aortic atresia ECMO with bilateral pulmonary artery band (PAB) Died at day 26 of life.
Banerji et. al. [37] 2020 Diagnosed after birth Clinically stable after birth Dextrocardia, discordant AV connections, DORV with pulmonary atresia. Proposed a univentricular strategy but parents declined intervention Unknown
Subramanian et al. [33] 2019 Postnatally Cyanosis and respiratory distress AV concordance, DORV, interrupted aortic arch Comfort care Died at home
Kishi et. al. [34] 2017 Diagnosed after birth severe hypoxia and bradycardia Asplenia, DORV, dysplastic tricuspid valve, and pulmonary stenosis. Supportive Died on the second day of life
Shati, et al. [35] 2015 Diagnosed after birth supraventricular tachycardia Concordant AV and discordant VA connections, and pulmonary atresia. Surgical shunt aiming for single ventricle approach Died postoperatively
Su, et. al. [36] 2014 Diagnosed after birth Cyanosis Concordant AV and VA connection, HLHS and aortic atresia. Atrial septectomy and bilateral PAB on day 1 of life. Norwood procedure with Sano modification day 5 of life. Unknown
Hwang et. al. [32] 2010 Diagnosed after birth Cyanosis Discordant AV connections, DORV with pulmonary atresia. Modified left BTT shunt at 33 days old Single ventricle pathway
Earing et. al. [29] 2003 5 days old Cyanosis Discordant AV connections, DORV with pulmonary atresia. Mee operation at 7 days old. Bidirectional Glenn shunt at 6 months old Single ventricle pathway
Yasukochi et. al. [28] 1999 9 months old Cyanosis, CHF Discordant AV connections, DORV with pulmonary stenosis. At 15 months of age, left BTT shunt. Died of congestive heart failure (CHF) and ventricular fibrillation at 17 years old.
Yasukochi et. al. [28] 1999 9 days old Cyanosis Discordant AV connections, DORV with pulmonary stenosis. Left BTT shunt at 23 days old Died of CHF and ventricular fibrillation at 13 months old

We report this unique case of congenital UMO in the setting of viscero-atrial situs solitus, AV concordance and DORV. Unlike other reported cases, the great arteries were normally related without aortic or pulmonary stenosis. The LV was severely dilated with extremely thin free walls and moderately depressed global LV systolic function. In our case, it was challenging to arrive at a definitive diagnosis by TTE and CMR was essential to establish a complete, final diagnosis. Our findings of diffuse fibrosis in the LV free wall has been demonstrated on previous autopsies [34]. To our knowledge, this is the first case of UMO that is reported with CMR images. Due to the patient’s clinical conditions, comfort care was provided for a several weeks after diagnosis. An autopsy was not performed.

The CMR of Case 3 can be found here: https://www.cloudcmr.com/6457–1973-0508–0124/Link does not work - please check.

5. Case 4: Left ventricular diverticulum masquerading as pseudoaneurysm

5.1. Clinical history

A 56-year-old African American male with known essential hypertension presented to the emergency department for an evaluation of elevated home blood pressure readings. On review of symptoms, patient reported mild, intermittent, self-limited, non-radiating mid chest tightness that would last for a few minutes and had been ongoing for past few days. There were no aggravating or relieving factors. Rest of review of symptoms were non-contributory. Patient denied any other medical problems and was currently not taking any medications. Patient denied any use of tobacco, alcohol, or any recreational substance. Family history was significant for history of stroke.

His vitals at presentation showed blood pressure of 175/114 mm Hg, heart rate of 76 beats per minutes, room air oxygen saturation of 96%; the patient was afebrile. Physical examination was within normal limits. His presentation ECG showed non-specific T wave inversions. His blood work including troponin were within normal limits except low-density lipoprotein was abnormal at 183 mg/dl (normal < 130 mg/dl), and D-dimer was minimally elevated. Chest CT with intravenous contrast excluded aortic dissection but demonstrated findings that were deemed concerning for LV pseudoaneurysm (Fig. 14). The patient was admitted for possible acute coronary syndrome and was treated with antihypertensive medications.

Fig. 14.

Fig. 14

Case 4. Fig. 1. Coronal view CTA. There is a presumed LV pseudoaneurysm (arrow).

The next morning, repeat troponin had remained normal. TTE showed LV septal abnormality (Fig. 15 and Additional movie File 9). Subsequently, patient underwent regadenoson stress with myocardial perfusion single photon emission computed tomography (SPECT) testing that did not demonstrate myocardial ischemia. He was discharged to home with plan to perform an outpatient CMR to better assess the LV septal abnormality.

Fig. 15.

Fig. 15

Case 4. Fig. 2. Parasternal short axis 2D TTE view. There is a LV diverticulum of the inferoseptal wall.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 8, Movie 9..

Movie 8

Case 3 Movie 3. Cine bSSFP short axis view. There is severe LV dilation with extremely thin anterior, inferior, and lateral walls. The LV moves in synchrony with the RV but with moderate global hypokinesia.

Download video file (37.3KB, mp4)
Movie 9

Case 4 Movie 1. Parasternal short axis color Doppler TTE. There is color flow in and out of the LV diverticulum.

Download video file (991.5KB, mp4)

5.2. CMR findings

CMR performed at 1.5 T (Signa Excite, General Electric HealthCare, Chicago, Illinois, USA) demonstrated a pouch (21 ×31 mm) at basal to mid inferior and infero-septal segments with a narrow neck measuring 9 mm (Fig. 16, Additional Movie File 10). LGE acquisitions did not show evidence of infarction, and there was no evidence of any infiltrative or inflammatory process (Fig. 17).

Fig. 16.

Fig. 16

Case 4. Fig. 3. Two chamber cine balanced steady state free precession (bSSFP) at end-diastole. There is a diverticulum with a narrow neck involving basal to mid inferior LV segments.

Fig. 17.

Fig. 17

Case 4. Fig. 4. Two chamber LGE view. There is no LGE present of the myocardium surrounding the diverticulum.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 10..

Movie 10

Case 4 Movie 2. Two chamber (A), four chamber (B), and mid short axis (C) cine bSSFP. There is a LV diverticulum of the inferior basal to mid walls.

Download video file (80.4KB, mp4)

5.3. Conclusion

Initially, diagnosis of LV pseudoaneurysm was entertained and patient was referred for urgent left heart catheterization and surgical consultation. His left heart catheterization showed no obstructive coronary artery disease (CAD). He was offered surgical intervention, but declined. Subsequent, CMR at 4-month follow-up showed a stable aspect of the LV pseudoaneurysm (Additional Movie File 11).

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 11..

Movie 11

Case 4 Movie 3. Four month follow-up mid short axis (A) and two chamber (B) cine bSSFP. The LV diverticulum of the basal to mid inferior wall is unchanged.

Download video file (94.7KB, mp4)

This case was discussed in multimodality imaging conference and with five different CMR experts. Given, no interval change at 4-month follow-up CMR, and absence of LGE, it was concluded that the abnormality represented congenital LV diverticulum rather than LV pseudoaneurysm. At 7-month follow-up from his initial presentation, patient continues to do well.

5.4. Perspective

LV diverticulum is a rare congenital abnormality that has been reported in 0.4% of cases at autopsy, with its first description dating back to 1816[38]. Congenital LV diverticulum has been classified into two different types [38], [39]. Muscular type, which contains mostly muscle fibers and usually arises from the LV apex and has synchronous contraction with the LV and has a narrow neck [38], [39]. This type may associate with other congenital defects such as Cantrell syndrome [38], [39]. The other type is fibrous diverticulum, which mostly consists of fibrous tissue and lacks contractile function[38], [39]. Fibrous diverticulum usually involves the inferior basal surface of the LV with a narrow neck [38], [39]. Congenital LV diverticulum may be incidentally discovered such as in our case or they may associate with other complications such as arrhythmias, systemic embolism, valvular regurgitation, and spontaneous rupture [38], [39], [40], [41], [42]. Optimal treatment for congenital LV diverticulum remains elusive with most authors choosing to observe if the patient remains asymptomatic [38], [39], [40], [41], [42].

It is imperative to make a clear distinction between LV congenital diverticulum, LV aneurysm, LV pseudoaneurysm, and LV crypts, see Table 2. LV pseudoaneurysm usually presents as a complication of MI and is defined as a contained myocardial rupture that is contained by adhering tissue, LV pseudoaneurysm depending on clinical circumstances may require a surgical intervention [38], [39], [40], [41], [42]. Pseudoaneurysm cavity has a narrow neck in sharp contrast to LV aneurysm, which contains all three layers of the LV that balloon out both in systole and diastole and has a wide neck [38], [39], [40], [41], [42]. LV aneurysm is medically managed in most cases [38], [39], [40], [41], [42]. Congenital LV diverticulum usually have a narrow neck and may be of muscular or fibrous type, but clinical presentation and LGE findings may differentiate this from LV pseudoaneurysm [38], [39], [40], [41], [42]. Finally, LV crypts are believed to be congenital in etiology and represent discrete fissures or clefts in compacted myocardium that may completely obliterate during systole[41]. Clinical significance of LV crypts remains unclear; however, they are frequently seen in hypertrophic cardiomyopathy and in hypertensive heart disease[41], [42]. In summary, differentiating LV diverticulum from LV pseudoaneurysm, LV aneurysm, and LV crypts may influence clinical decision making and thus medical management.

Table 2.

Case 4. Summary of left ventricular aneurysm, pseudoaneurysm, diverticulum, and cleft.

Location Opening Surrounding Wall Contractility Etiology and Associations
Left ventricular aneurysm Variable Wide neck Endocardium, myocardium, and epicardium-fibrotic walls Akinetic or dyskinetic with ballooning of involved segments Usually complication of coronary artery disease. Other causes may include sarcoidosis, HCM, iatrogenic, trauma, Chaga’s disease, mucopolysaccharidosis etc.
Left ventricular pseudo-aneurysm (Contained rupture) Variable Narrow neck Pericardium Akinetic Usually complication of coronary artery disease, other causes may include iatrogenic, trauma, infective endocarditis etc.
Left ventricular fibrous diverticulum Usually basal inferoseptal segment of the LV Narrow neck Fibrotic wall composed of reticulin fibers, may have some muscle fiber Akinetic or dyskinetic Congenital, and usually does not associate with other congenital anomalies
Left ventricular muscular diverticulum Usually apical segment of the LV Usually narrow neck but can have wide neck Endocardium, myocardium, and epicardium Contracts synchronously with the LV Congenital, and may associate with midline thoraco-abdominal congenital abnormalities (Cantrell syndrome)
Left ventricular crypts/ clefts/ fissures/ crevices Usually Inferior or septal wall of the LV Usually narrow and may completely obliterate during systole Discrete fissure or cleft in compacted myocardium lined by endocardium Contracts synchronously with the LV Congenital, frequently associate with HCM and hypertensive heart disease

The CMR of Case 4 can be found here: https://www.cloudcmr.com/7957–1973-1598–0111/. The follow-up CMR can be found here: https://www.cloudcmr.com/3057–1973-3748–0142/). .

6. Case 5: COVID-19 vaccine-related myocarditis

6.1. Clinical History

A 16-year-old male was referred for CMR 6 months after an episode of COVID-19 vaccine-related myocarditis (CVAM). He had previously been admitted to an outside hospital with mid-sternal chest pain three days after the second dose of Pfizer-BioNTech COVID-19 vaccine. There was no associated fever, shortness of breath, palpitations, or dizziness. Laboratory work-up revealed elevated inflammatory markers and troponin I level (peak = 9.78 ng/ml, normal value ≤0.08 ng/ml). The work-up was negative for other infectious, rheumatologic and toxicologic etiologies. There was no evidence of other end-organ damage. ECG showed ST segment elevations in precordial leads V4-V6 without arrhythmias.

TTE showed preserved global LV systolic function. Coronary angiography demonstrated normal coronary artery anatomy. CMR (images not available) obtained four days after the dose showed a normal LVEF, elevated native T1 and T2 values, and extensive subepicardial and midmyocardial LGE in the LV lateral wall. He was treated with IVIG. The patient was asymptomatic at discharge, with a significant decrease in troponin level to 0.24 ng/ml.

6.2. CMR findings

CMR obtained six months after the initial presentation showed normal LV and RV size and global systolic function (LVEF 64%, RVEF 61%), without evidence of regional wall motion abnormality (Additional Movie File 12). T2 STIR images demonstrated no evidence of focal edema (Fig. 18). Global extracellular volume (ECV) (29%; reference range 20–32%; Fig. 19) and T2 (48 ms) values were normal (Fig. 19), however focal ECV elevation was noted in the LV mid lateral wall (41%)[43]. Midmyocardial LGE was noted in the LV mid-to-basal lateral wall (Fig. 20).

Fig. 18.

Fig. 18

Case 5. Fig. 1. Short axis stack T2 short tau inversion recovery (STIR) images. There is no evidence of myocardial edema.

Fig. 19.

Fig. 19

Case 5. Fig. 2. Native T1 (A), extracellular volume (ECV, B), and native T2 (C) maps mid short axis view. There is a regional increase in ECV along the LV lateral wall and normal T1 and T2 map values.

Fig. 20.

Fig. 20

Case 5. Fig. 3. Short axis stack (A) and four chamber stack (B) LGE images. There is patchy subepicardial and midmyocardial enhancement in the mid-to basal LV lateral wall.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 12..

Movie 12

Case 5 Movie 1. Cine short axis stack bSSFP. There is normal LV and RV chamber size and global systolic function with no regional wall motion abnormalities present.

Download video file (253.5KB, mp4)

6.3. Conclusion

These findings are consistent with prior myocarditis with residual fibrosis. During the follow-up period, the patient reported occasional palpitations. However, serial Holter monitors did not reveal any arrhythmia. The long-term implications of residual fibrosis remain unknown, and the patient will require close follow-up.

6.4. Perspective

Since COVID-19 vaccines were approved for children aged 12 and older, multiple reports of CVAM have been published [44], [45], [46], [47], [48]. CVAM has predominantly affected white adolescent males. The vast majority of cases involved the messenger ribonucleic acid (mRNA) vaccines and presented after the second dose. The most common presenting symptom was chest pain. Most patients presented with normal LV systolic function. Two North American multicenter studies have shown that 51–88% of CMR studies in the acute phase met Lake Louise Criteria [47], [48]. Hospital course was relatively benign. Most hospitalizations lasted under a week, without the need for intensive care unit admission or inotropic support. Arrhythmias were rare. These findings differ from other forms of pediatric myocarditis, which overall have a higher rate of LV dysfunction, need for inotropic support, and arrhythmia burden [49]. The long-term prognosis of CVAM remains unknown. This case highlights the importance of close follow-up of these patients. The utility of CMR in the diagnosis of myocarditis is well established. In a pediatric population, the typical findings of myocarditis on CMR generally obviate the need for further dedicated coronary angiography. Despite having a relatively benign clinical course and normal TTE evaluations in follow-up period, this patient showed residual fibrosis six months after the onset of CVAM. The clinical significance of LGE after CVAM remains unknown. However, large outcome studies of myocarditis in adults have consistently shown adverse outcomes associated to LGE[50], [51], [52].

The CMR of Case 5 can be found here: https://www.cloudcmr.com/5557–1973-0898–0104/).

7. Case 6: Child with fulminant myopericarditis and tamponade after COVID-19

7.1. Clinical history

An 8-year-old previously healthy male with a past medical history of mild persistent asthma, unvaccinated against COVID-19, was admitted with abdominal pain, emesis, and bilateral hip and thigh pain. He was diagnosed with acute COVID-19 by initial rapid molecular testing which was subsequently confirmed by PCR testing with negative antibody testing. He had no preceding fevers. Physical examination was notable for poor peripheral perfusion. Initial inflammatory markers were normal, and an ECG demonstrated low voltages (Fig. 21). He required fluid resuscitation both in the emergency department and pediatric intensive care unit but eventually required inotropic support with epinephrine and milrinone. Chest CT showed extensive bilateral lung opacities and atelectasis, consistent with COVID-19 pneumonia (Fig. 22). Cardiac workup showed elevated troponin (peak 2.47 ng/ml; normal <0.029 ng/mL) and brain natriuretic peptide (BNP) (peak 2.4 pg/ml; normal <60 pg/mL). Initial TTE showed severe LV systolic dysfunction (LVEF 31%) without LV dilation (LV end-diastolic diameter 3.57 cm, z-score −1.8) with a moderate-sized circumferential pericardial effusion (Additional Movie File 13) with a maximum dimension of 1 cm from subcostal imaging.

Fig. 21.

Fig. 21

Case 6. Fig. 1. Twelve lead electrocardiogram (ECG) on admission. There is sinus tachycardia with diffuse low voltages present.

Fig. 22.

Fig. 22

Case 6. Fig. 2. Coronal chest CTA. There are extensive bilateral lung opacities and atelectasis present.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 13..

Movie 13

Case 6 Movie 1. Parasternal short axis TTE view. There is severe LV systolic dysfunction and moderate pericardial effusion present.

Download video file (700.2KB, mp4)

The patient was treated with IVIG, remdesivir, and methylprednisolone. Due to increased air hunger, emesis, and aspiration, he suffered an in-hospital cardiac arrest requiring chest compressions with return of spontaneous circulation. For tenuous hemodynamics and persistent hypoxia, he was ultimately placed on venovenous extracorporeal membrane oxygenation (ECMO) support on hospital day 5 with concomitant percutaneous pericardiocentesis. He was decannulated on hospital day 8 without incident, transferred to the ward on hospital day 11, and discharged home in stable condition on hospital day 16. His troponin and BNP levels peaked while on ECMO support, then trended down and normalized prior to discharge. CMR was performed within 2 weeks of discharge, but 7 weeks from onset of symptoms.

7.2. CMR findings

CMR was performed at 3 T (Magnetom Skyra, Siemens Healthineers AG, Erlangen, Germany) without sedation to evaluate cardiac function and for tissue characterization. There was normal bi-ventricular size and systolic function (LVEDVI 72 mL/m2, LVEF of 61%, RVEDVI 81 mL/m2) without significant residual pericardial effusion (Additional Movie File 14). T2w imaging showed increased signal intensity in the mid-LV inferior wall, extensive pericardial LGE, and elevated ECV (Fig. 23, Fig. 24, Fig. 25). Findings were consistent with myopericarditis.

Fig. 23.

Fig. 23

Case 6. Fig. 3. T2w triple inversion recovery short axis mid slice. There is increased signal intensity in the inferior LV wall.

Fig. 24.

Fig. 24

Case 6. Fig. 4. Short axis (A) and four chamber (B) LGE images. There is enhancement of the pericardium (arrows) consistent with pericarditis.

Fig. 25.

Fig. 25

Case 6. Fig. 5. Native T1 (A), ECV (B), and native T2 (C) mid short axis slices. Normal global native T1 value of 1210 msec (institutional normal < 1270 msec), increased global ECV of 33% (institutional normal < 29%) with patchy areas of further hyperintensity at the mid-inferoseptal (33.9%) and lateral wall (34.8%, arrows). The increased ECV values in the clinical context was interpreted to represent residual myocardial inflammation and edema. The global T2 value was normal at 33 msec and this slice was not the same slice on T2 short tau inversion recovery (STIR).

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 14..

Movie 14

Case 6 Movie 2. Two chamber (A) and four chamber (B) cine bSSFP views. There is normal bi-ventricular size and systolic function with mild mitral regurgitation and no significant residual pericardial effusion.

Download video file (142.2KB, mp4)

7.3. Conclusion

Clinical course was consistent with COVID-19 pneumonia with fulminant myopericarditis. CMR findings were consistent with pericarditis with evidence of residual myocardial inflammation/edema, but otherwise recovered cardiac function. Positive prognostic indicators were the paucity of LGE and normal strain values in the setting of normal LVEF. This case highlights the tumultuous course and cardiac involvement that can be seen, even in pediatric patients with severe COVID-19 illness, the recovery of cardiac function that can be seen during the convalescent phase of illness, and the spectrum of CMR findings in pediatric patients including pericardial involvement and myocardial inflammation/edema.

7.4. Perspective

One of the key findings is that acute COVID-19 can result in critical illness, even in children. Our 8-year-old patient unfortunately had fulminant myopericarditis with COVID-19, without evidence of MIS-C. CMR has two important roles in the management of this patient. First, results of parametric mapping, LGE imaging, and strain imaging have all been shown to be strong prognostic indicators in myocarditis [53]. Second, there is a clear association between mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the rare complication of myocarditis/pericarditis, particularly in young males [54]. Current United States Centers for Disease Control and Prevention recommendations state that mRNA vaccination should be deferred until the episode of myocarditis or pericarditis has completely resolved [55]. Given the excellent tissue characterization offered by CMR, even in young children, a follow-up CMR to ensure resolution of active myocardial and pericardial inflammation, particularly in this case with significant myocardial and pericardial abnormalities, may be prudent prior to vaccination.

Our patient met the diagnostic criteria for fulminant myocarditis based on the history of acute illness (presentation with COVID-19 pneumonia, negative SARS-CoV-2 antibodies) and cardiogenic shock requiring inotropic support [56]. While long-term outcome after survival from fulminant myocarditis is favorable in adults, these findings may not be applicable to pediatric patients [57]. After recovery and discharge from the hospital, the patient's CMR demonstrated normalization of biventricular function (Additional Movie File 14) and no myocardial LGE (Fig. 24). However, he was noted to have residual myocardial edema (Fig. 23) and ECV elevation (Fig. 25) 7 weeks from the onset of his symptoms. This may represent lingering subacute myocarditis, with the ECV elevation representing myocardial hyperemia/inflammation, especially in the setting of the persistent T2-STIR abnormality. Residual T1 and T2 abnormalities have been reported past 8 weeks in some patients [58]. However, continued elevation on follow-up may represent chronic indolent myocarditis, or possibly development of diffuse interstitial fibrosis, which is associated with worse outcomes over time[59]. Persistent myocardial abnormalities after acute COVID-19 infection have also been shown in several studies, and the true mechanism of myocardial injury after COVID-19 remains unknown [60], [61]. Fortunately, his myocardial deformation by strain encoded (SENC) imaging appears normal, with recent studies showing the additive value of strain assessment to predict prognosis, particularly in those with normal LVEF [62]. Both LV global longitudinal (GLS) (-18.3%; normal < −17%) and global circumferential (GCS) (-19%; normal < −18%) strain were normal [63].

The finding of pericardial LGE (Fig. 24) is an interesting finding given the association between mRNA COVID-19 vaccines and the development of myopericarditis. Although his biventricular function, cardiac biomarkers, and clinical symptoms have improved, he continued to demonstrate abnormalities on CMR, demonstrating its exceptional capabilities in myocardial tissue characterization. We plan to repeat CMR at 6 months to re-evaluate his myocardium and pericardium prior to clearing him to receive COVID-19 vaccinations. The family has continued to express support for vaccinating our patient, in part due to his severe illness.

The CMR of Case 6 can be found here: https://www.cloudcmr.com/8957–1973-4618–0189/). .

8. Case 7: RVOT thrombosis without valvular extension in a repaired tetralogy of Fallot patient

8.1. Clinical history

A 46-year-old female with a history of asthma and tetralogy of Fallot (TOF) was evaluated for progressive dyspnea, chest pain, and palpitations. She underwent transannular patch repair at age 8. Ten years prior to presentation, due to severe pulmonic regurgitation, RV dilation (RVEDVI 180 mL/m2; normal 57–95 ml/m2), and declining RV systolic function (RVEF 37%; normal 53–77%), she underwent bioprosthetic pulmonary valve replacement (PVR; 29 mm Mosaic bioprosthetic valve, (Medtronic, Dublin, Ireland)), aneurysmectomy, and RVOT revision with placement of a GORE-TEX patch (W.L. Gore & Associates, Newark, Delaware, USA) to enlarge the RVOT diameter.

On current presentation, the cardiovascular exam revealed a single S1, widely split S2 varying with respiration due to right bundle branch block (RBBB), 1/6 systolic ejection murmur and early-mid diastolic murmur best heard at the left sternal border. Holter monitor identified sinus rhythm with frequent premature atrial contractions, occasional ectopic atrial rhythm, occasional premature ventricular contractions, and one 10-beat run of asymptomatic ventricular tachycardia. TTE compared to prior TTE showed a 5–10% decline in LVEF due to global mild hypokinesis, mild-moderate aortic valve regurgitation, and mildly low RVEF due to akinesis of the RVOT. Furosemide was started, yielding resolution of paroxysmal nocturnal dyspnea but dyspnea upon walking 25–50 meters on flat ground persisted. She was referred for right and left heart catheterization, which demonstrated mildly elevated right heart filling pressures (RV pressure 75/20 mmHg; RA mean 12 mmHg), moderate pulmonary arterial hypertension (59/33 mmHg, mean 41 mmHg), and severely elevated left-sided pressures (LV end diastolic pressure 41 mmHg) with systemic hypertension (aortic pressure 161/85 mmHg). Selective coronary angiography revealed no obstructive CAD. Intravenous diuretics and afterload reduction were initiated. CMR was obtained for a definitive assessment of biventricular volumes, function, and tissue characterization.

8.2. CMR findings

CMR at 1.5 T (Avanto, Siemens Healthineers AG, Erlangen, Germany) revealed a mildly dilated LV (LVEDVI 115 mL/m2; normal 58–94 ml/m2) with moderately depressed systolic function due to global hypokinesis (LVEF 35%, Fig. 26). The RV was mildly dilated (RVEDVI 108 mL/m2 (normal 57–95 ml/m2)) with severely depressed systolic function due to global hypokinesis and infundibular akinesis (RVEF 25%, Fig. 26). There was moderate-severe aortic regurgitation (22 mL, 40% regurgitant fraction, holodiastolic flow reversal in the descending thoracic aorta), moderate tricuspid regurgitation (30% regurgitant fraction), and well-seated 29 mm Mosaic bioprosthetic PVR with mild stenosis (peak velocity estimated 2.8 m/s) without significant regurgitation. A 15 × 53 mm, sessile, laminated thrombus without a mobile component was identified along the akinetic RVOT at the site of the GORE-TEX RVOT patch (Fig. 27, Fig. 28, Fig. 29).

Fig. 26.

Fig. 26

Case 7. Fig. 1. Mid short axis (A), two chamber (B), basal short axis (C), and four chamber (D) cine bSSFP at end-diastole. There is a 15 × 53 mm mass in the RV outflow tract. The LV and RV are mildly dilated.

Fig. 27.

Fig. 27

Case 7. Fig. 2. Mid short axis cine bSSFP (A), phase sensitive inversion recovery (PSIR) with inversion time (TI) 600 msec (B), and PSIR with null TI (C), and ECV map (D). The RV outflow tract thrombus (arrows) is well seen.

Fig. 28.

Fig. 28

Case 7. Fig. 3. Short axis stack PSIR LGE imaging with dark blood technique. There is significant basal-mid RV outflow tract (RVOT), anterosuperior free wall, and RV endocardial anteroseptal at the ventricular septal defect (VSD) patch site hyperenhancement with a large, laminated RVOT thrombus (yellow arrows). There is a punctate apical inferolateral transmural hyperenhancement from prior LV vent site (blue arrows).

Fig. 29.

Fig. 29

Case 7. Fig. 4. Basal short axis PSIR LGE image. The RVOT thrombus is interposed between transannular patch and VSD patch. Dense hyperenhancement is seen at the anterior right ventricular free wall, infundibulum, and endocardial septum.

8.3. Conclusion

Prior to initiating therapeutic anticoagulation for the thrombus identified on CMR, chest CTA was performed and confirmed a laminated thrombus in the RVOT without peripheral embolic changes in either lung and without pseudoaneurysm, perforation, or RVOT disruption (Fig. 30 Case 7 Fig. 5). A direct oral anticoagulant and guideline-directed medical therapy for a nonischemic cardiomyopathy were initiated with apixaban and sacubitril/valsartan.

Fig. 30.

Fig. 30

Case 7. Fig. 5. Off axis sagittal computed tomography angiogram. There is a thrombus (arrows) in the RVOT.

Three months later, the patient reported improved dyspnea on exertion with no limitation while walking on flat ground. At 16 month follow-up, the patient reported resolution of all symptoms. CMR revealed mild LV dilatation (LVEDVI 111 ml/m2), normal LV systolic function (LVEF 55%), normal RV size (RVEDVI 90 ml/m2), low normal RV systolic function (RVEF 44%), mild-moderate aortic regurgitation (regurgitant fraction 16%), bioprosthetic PVR with ongoing mild pulmonic stenosis and no significant pulmonic regurgitation, and resolving, non-mobile, mural laminar thrombus along the RVOT patch measuring 7×40 mm (Fig. 31).

Fig. 31.

Fig. 31

Case 7. Fig. 6. Mid short axis cine bSSFP follow-up. There is a 7 × 40 mm thrombus (arrow) along the RVOT patch.

8.4. Perspective

Isolated, in situ RVOT thrombosis has not previously been reported after RVOT patching in TOF, except in the setting of a large RVOT aneurysm[64]. The formation of RVOT thrombus in this case likely arose from multiple factors including flow distortions, prosthetic material/abnormal endothelium, and akinesia of the RV free wall. Gore-Tex cardiac patch is a prosthetic material composed of polytetrafluoroethylene that is used as a conduit in various congenital heart disease repairs, including transannular patch for TOF repair. Thrombosis associated with Gore-Tex material, although rare, has been reported previously involving a Blalock-Thomas-Taussig (BTT) shunt, a central shunt, and Fontan palliation [65], [66], [67].

CMR has been used to investigate flow dynamics in repaired TOF, and 4D flow studies have shown a variety of altered flow hemodynamics among these patients [68]. During RV systole, increased vortices can be observed in the RVOT because of pulmonary insufficiency countering antegrade systolic flow [69]. The interaction of the antegrade systolic jet with the pulmonary regurgitant jet may create variable intracardiac topology that forms shear layers and more turbulent-like flow [70]. Abnormal RV direct flow, a measure of blood entering and exiting the ventricle within the analyzed cycle and the main determinant of RV intracavity blood flow kinetic energy, has been shown to be lower in patients with repaired TOF in comparison to controls [71]. Thus, altered flow dynamics secondary to the nature of TOF disease along with RV dysfunction as evidenced by akinesia of the free ventricular wall were likely compounded by the presence of prosthetic material, leading to a milieu predisposing to thrombus formation.

With initiation of anticoagulation and guideline-directed medical therapy (GDMT) for non-ischemic cardiomyopathy, there has been sustained, marked improvement in biventricular function. Although counterintuitive at first take, LV systolic dysfunction is more common among adult CHD patients with biventricular repair and right-sided disease (like TOF) than those with left-sided disease (i.e. subaortic stenosis, coarctation of the aorta; 15% vs. 10%, p > 0.001) [72]. While prior studies have been equivocal about the association of GDMT with improved ventricular systolic function, Egbe et al. found that GDMT improved LVEF and lowered the risk of cardiovascular events among patients with right-sided lesions (including those with TOF) [72]. Mechanistically, LV recovery may be related to reductions in afterload to both pulmonary and systemic vascular systems (with normotension also helping reduce the degree of aortic regurgitation), improved ventriculo-ventricular interactions, such as improved LV twist, as well as decongestion given this patient’s presentation with hypervolemia and severely elevated left-sided filling pressures. Ventricular interdependence has previously been well-described with RV dysfunction and dilation adversely affecting LV function and geometry, and RV dysfunction secondary to the underlying substrate of repaired TOF with akinesia compounded by thrombus in the RVOT likely worsened biventricular dynamics [73]. Direct oral anticoagulant use likely aided in resolution of the RV thrombus based on a reduction in size seen on follow-up CMR. Impaired LV twist, not uncommon in TOF patients, is suggested by apical LGE in this patient, and it may also factor into LV dysfunction. CMR was therefore helpful in not only identifying the RVOT thrombus, but also quantifying ventricular performance and guiding medical therapy.

In repaired TOF patients, CMR is integral to follow-up imaging for characterization of volumetrics, function, tissue characterization, and flow dynamics while also having utility for evaluating other pathology such as tricuspid regurgitation and aortic regurgitation. CMR further aids in mortality risk prediction and can identify rare complications, such as the RVOT thrombus seen in this case[74].

The CMR of Case 7 can be found here: https://www.cloudcmr.com/7157–1973-2568–0187/).

9. Case 8: LGE in neonate

9.1. Clinical history

A near term newborn with maternal history of chorioamnionitis was admitted to the neonatal intensive care unit for respiratory distress after birth. He was managed as per the unit protocol for neonatal sepsis. He was soon noted to have persistent atrial tachycardia requiring rate control with medical therapy, after attempts at cardioversion with vagal maneuvers, adenosine and synchronized cardioversion failed. Initial TTE revealed normal cardiac anatomy with normal myocardial contractile function. He subsequently developed myocardial dysfunction and low cardiac output state requiring inotropic support. There was mild troponin leak (800 pg/ml, normal <45 pg/ml) and detection of enterovirus in blood by PCR raising suspicion of neonatal myocarditis.

A CMR (1.5 T, Ingenia, Philips Healthcare, Best, Netherlands) at 2 weeks of age revealed depressed LV contractile function (LVEF 41%) with no LGE (Fig. 32). The patient clinically improved with supportive therapy. Follow up serial TTE revealed improving LV systolic function with new findings of patchy subendocardial focal areas of brightness in the basal- and mid-septal walls. A repeat CMR was requested at 4 weeks of age.

Fig. 32.

Fig. 32

Case 8. Fig. 1. Basal short axis LGE image. No hyperenhancement at the 2 week scan.

9.2. CMR findings

The repeat CMR using neonatal protocol was performed at 1.5 T (Ingenia, Philips Healthcare, Best, Netherlands) avoiding sedation using the ‘feed and swaddle’ method [75]. CMR revealed normal LV dimensions (LVEDVI 44 ml/m2, normal 36–53 ml/m2) with normal LV mass (LV mass indexed 41 g/m2, normal 27–42 g/m2) and systolic function (LVEF 71%; >54%). There was focal diminished systolic thickening of the basal anteroseptal and basal inferoseptal LV segments (AHA segments 2,3) (Additional Movie File 16).

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 15, Movie 16..

Movie 15

Case 6 Movie 3. Four chamber strain encoded imaging measuring circumferential strain. The patient’s LV global longitudinal (GLS) and global circumferential strain (GCS) were both normal at −18.3% and −19%, respectively (institutional control data with normal values of LV GLS < −17% and LV GCS < −18%).

Download video file (161.6KB, mp4)
Movie 16

Case 8 Movie 1. Short-axis bSSFP cine from base to apex. Normal LV and RV size and global systolic function present. There was diminished systolic thickening of the basal septal segments.

Download video file (437.2KB, mp4)

LGE imaging was performed immediately after administration of gadolinium contrast [0.62 mmol (0.2 mmol/kg); Gadavist® (Bayer HealthCare, Berlin, Germany)] to account for the rapid washout of contrast in the setting of high neonatal heart rates. A respiratory motion-compensated free-breathing gradient echo T1w phase sensitive inversion recovery (PSIR) sequence was used. Inversion time was selected from a modified Look-Locker inversion recovery sequence (MOLLI) based on the inversion time where myocardium was best nulled. Thin (6 mm) myocardial slices in the short axis were acquired through the ventricles with a field-of-view of 200 mm and in plane spatial resolution of 1.6×1.9 mm.

Acceleration techniques included a sensitivity encoding (SENSE) factor of 1.8 and signal averaging of 2. Mid diastolic imaging with shortened read-out window (50ms) was obtained at every 4th R-R interval to account for the fast heart rate. This revealed sub-endocardial partial thickness LGE of the AHA segments 2 and 3 (Fig. 33). These findings were consistent with neonatal thromboembolic MI.

Fig. 33.

Fig. 33

Case 8. Fig. 2. Magnitude and PSIR four chamber (A) and basal short axis (B) images. Sub-endocardial partial thickness LGE of the basal septal myocardium.

9.3. Conclusion

Neonatal MI in the infant is suspected to be the result of a perinatal thromboembolic event. Paradoxical embolism through the foramen ovale or the ductus arteriosus can occur in the fetus in association with umbilical cord hematoma, umbilical venous catheterization, prenatal renal vein thrombosis and many times, without obvious sources [76].

The patient continued to improve clinically with supportive therapy and was discharged at 4 weeks of age. Since then, he has been asymptomatic, showing normal growth and development, no arrythmias and normal cardiac function. He was continued on betablocker therapy for arrythmia control with no significant side effects.

9.4. Perspective

LGE CMR imaging sequence is increasingly used in the evaluation of pediatric cardiovascular disorders. It is seen as a result of extracellular space expansion, either from acute cell damage or chronic scarring or fibrosis. LGE imaging in neonates and young infants is challenging but feasible.

The challenge of imaging in the setting of high neonatal heart rates is overcome using acceleration techniques and adjusting the acquisition window (views per segment) to the heart rate [77], [78]. To account for the small heart size in neonates using a smaller field-of-view (200 mm) and thinner slices (5–6 mm) gives an adequate spatial resolution. These measures, however, decrease the voxel size resulting in a low signal-to-noise ratio. This is improved by using the smallest available coil (eg. a smaller pediatric multi-element cardiac phased-array coil) and signal averaging. Motion compensation is used to account for the respiratory motion.

Typically, 180-degree inversions are placed every two R-R intervals for LGE sequences to allow for recovery of the longitudinal signal between successive inversion pulses. However, this is not feasible at high heart rates and triggering is altered to every 4th R-R interval in neonates. This may require manually halving the heart rate to ‘trick’ the scanner into increasing the acquisition window. Lastly, neonates have a higher rate of wash out of the gadolinium contrast agent from the myocardium, necessitating minimal delay in obtaining the LGE images after contrast administration.

The CMR of Case 8 can be found here: https://www.cloudcmr.com/4857–1973-2758–0156/).

10. Case 9: Concomitant dual genetic cardiomyopathies in a patient complicated by stroke

10.1. Clinical history

A 60 year-old female was referred to our cardiology clinic to investigate asymptomatic ECG abnormalities detected during workup for elective hemicolectomy for malignancy. Her medical history included rheumatoid arthritis, obstructive sleep apnea, osteoarthritis and obesity. Her younger half-brother died in his 50′s from sudden cardiac death whilst playing sports. Medications included metoprolol and warfarin. Physical examination was unremarkable. Her ECG demonstrated rightward-axis deviation, RBBB, T-wave inversion in leads V1 to V4 and small positive deflections at the end of the ECG in leads V3 to V5 (Fig. 34). Her TTE demonstrated severe asymmetrical LV wall thickening (provide wall thickness data), akinesis of all apical segments, and a mass in LV apex (Additional Movie File 17). Coronary angiography showed no significant CAD (Fig. 35). She was referred for CMR to further investigate her cardiomyopathy and suspected LV apical thrombus.

Fig. 34.

Fig. 34

Case 9. Fig. 1. Twelve lead ECG. There is rightward axis with right bundle branch block and epsilon waves in leads V3 to V5 (arrows).

Fig. 35.

Fig. 35

Case 9. Fig. 2. Anteroposterior (A) and lateral (B) projections during invasive coronary angiography. There is normal left sided and right coronary artery anatomy.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 17..

Movie 17

Case 9 Movie 1. Four chamber TTE without (A) and with (B) contrast enhancement. There is asymmetric severe LV wall hypertrophy, akinesia of apical segment, and a small hypointense mass in the apex.

Download video file (461.1KB, mp4)

10.2. CMR findings

The CMR study was performed on 1.5 T (Magnetom Vida, Siemens Healthineers AG, Erlangen, Germany) with sinus rhythm of 72 bpm. Cine imaging demonstrated normal LV size (LVEDVI 78 ml/m2, normal 51–84 ml/m2) and normal LVEF of 55% (normal 53–77%) (Additional Movie File 18). Aneurysmal dilatation of LV apical segments was present with a 17×13 mm thrombus (Additional Movie File 19). There was no evidence of non-compaction. Increased LV wall thickness was seen in the basal-to-mid septal segments with maximal thickness of 21 mm (Additional Movie File 19). Papillary muscles demonstrated normal structure and attachment. Systolic anterior motion of mitral leaflets was present. The RV was dilated (RVEDV 240 mL) and RVEF was depressed at 27% (Additional Movie File 19). “Accordion” sign was present in the subtricuspid RV free wall and associated with dyskinesis and microaneurysmal changes (Additional Movie File 19). The “accordion sign” has been described in the literature as focal crinkling of the RV free wall, typically in the sub-tricuspid or the RVOT region, that is caused by multiple sequential outpouching that do not reach microaneurysmal size[79]. Parametric mapping was not available. LGE imaging demonstrated patchy mid-wall scar in the hypertrophied LV segments but no obvious confluent scar was seen in LV apex (Fig. 36). Myocardial scar comprised 14% of total LV myocardium. There was subtle LGE in the sub-tricuspid region of the RV free wall (Fig. 36).

Fig. 36.

Fig. 36

Case 9. Fig. 3. Two chamber (A) and four chamber (B) (LGE images. There is patchy mid myocardial LGE in the LV inferior wall often seen in hypertrophic cardiomyopathy. There is LV apical aneurysm without confluent myocardial scarring and presence of a thrombus confirmed by avascularity of the mass. There is subtle LGE in the sub-tricuspid region of the RV free wall often seen in arrhythmogenic cardiomyopathy (B).

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 18, Movie 19..

Movie 18

Case 9 Movie 2. Cine bSSFP short axis stack. There is asymmetrically increased LV wall thickness (maximum diameter 21 mm) of basal to mid septal and anterior segments with LV apical aneurysm and probable thrombus. Small pericardial effusion is present.

Download video file (381.1KB, mp4)
Movie 19

Case 9 Movie 3. Cine bSSFP two chamber (A), three chamber (B), four chamber (C), and RV outflow tract (D) views. There is severe asymmetrical increased LV wall thickness (A-C) and systolic anterior motion of the anterior leaflet of the mitral valve with dynamic outflow tract obstruction (B). Mass seen in the LV apex likely representing a thrombus (A). Dyskinetic systolic bulging of a microaneurysm can be seen in the RV outflow tract free wall (B,D) and dyskinetic aneurysm in RV inferior wall (D). The RV is dilated with “accordion sign” in the sub-tricuspid “triangle of dysplasia” (C). Note that small outpouching of apical RV free wall is due to tethering by moderator band and is a normal variant that may be mistaken for regional wall motion abnormality (C).

Download video file (115.4KB, mp4)

10.3. Conclusion

Genetic analysis revealed a pathogenetic mutation in the Plakophillin 2 (PKP2) gene and a strong class 3 A variant of uncertain significance (VUS) in the formin homology 2 domain containing 3 (FHOD3) gene, which is a gene associated with hypertrophic cardiomyopathy (HCM)[80]. Final diagnosis was concomitant genetic cardiomyopathies of arrhythmogenic cardiomyopathy and HCM due to digenic inheritance complicated by large LV apical aneurysm and thrombus.

10.4. Perspective

Based on CMR findings, patient underwent further investigations. Electrophysiology review of ECGs confirmed presence of epsilon waves (Fig. 34, arrows). Warfarin had been stopped one month prior to her CMR based on contrast-enhanced TTE report that suggested absence of thrombus. Warfarin was subsequently restarted 3 weeks after her CMR study; however, one week after that she suffered a stroke with large frontoparietal and basal ganglia infarction demonstrated on brain magnetic resonance imaging (MRI). Her international normalized ratio (INR) was subtherapeutic (INR 1.3) at time of stroke. She underwent prolonged rehabilitation course with excellent recovery. Family members were offered genetic counselling and cardiac screening every 3–5 years from childhood was recommended. Holter monitor showed sinus rhythm throughout with 0.5% burden of ventricular ectopics. From the arrhythmia specialist perspective, due to the patient being reluctant to consider an implantable cardioverter defibrillator (ICD) for primary prevention, the decision for a loop recorder with close rhythm monitoring was made with the option to upgrade to ICD implantation if further high-risk features were identified.

Arrhythmogenic cardiomyopathy diagnosis is supported by ECG, imaging and genetic findings and meets 2010 Revised Taskforce Criteria for diagnosis of arrhythmogenic cardiomyopathy [81]. Although it may be tempting to attribute both cardiomyopathic phenotypes to a single pathogenic gene variant, PKP2 pathogenic variants to date have not been associated with HCM phenotypes[82]. It is possible that cycles of temporarily ceasing and restarting anticoagulation based on alternating imaging modalities with differing sensitivities for thrombus may have contributed to thrombus instability and consequent stroke.

This case demonstrates coexistence of two separate cardiomyopathic phenotypes that is likely attributable to digenic inheritance and the presence of pathogenic variants in two different cardiomyopathy genes. Very little published literature is available regarding prevalence of co-existing cardiomyopathies.

If pathologic variants are inherited independently and assuming genetic cardiomyopathy prevalence of 0.2%, then it might be expected that 1 in 2500 individuals could have ≥ 2 pathogenic cardiac mutations. Features supporting a causal role of VUS in FHOD3 gene for HCM phenotype in this case include rarity of variant, in silico computational simulation predicts pathogenicity and comparable variant of uncertain significance examples display moderate pathogenicity. Further research in this clinical is needed. TTE imaging correctly identified presence of HCM but likely did not detect presence of persisting left thrombus presence and missed diagnostic imaging criteria for arrhythmogenic cardiomyopathy.

This case also highlights the central role of CMR in investigation and diagnosis of RV pathology. Indeed, it was only in the context of CMR findings that several relevant pre-existing features such as epsilon waves on ECG were finally recognized. Prior studies have shown TTE can only identify 50% of arrhythmogenic cardiomyopathy cases that are identified by CMR, which suggests that selective use of CMR may double number of identified cases of this potentially life-threatening disease [83], [84]. This case supports the concept that lowering testing threshold and improving access to advanced cardiac imaging can improve patient outcomes.

It should be recognized that despite accurate pathological diagnosis, CMR did not prevent patient from a potentially avoidable adverse outcome within days of testing. Warfarin was apparently ceased on basis of a negative contrast-enhanced TTE – however accuracy of contrast-enhanced TTE compared to LGE-CMR is only 61% and it is likely this TTE finding was a false-negative given subsequent CMR findings [85].

Patient’s use of hydroxychloroquine briefly raised the possibility of hydroxychloroquine cardiotoxicity, which is a recognized phenocopy of HCM [86]. However, several features of this case made hydroxychloroquine less likely including absence of bradycardia, presence of potentially pathological mutation in gene associated with HCM, presence of asymmetrical hypertrophy and presence of systolic anterior mitral motion and of apical aneurysm [86]. If hydroxychloroquine is continued then it may be reasonable to repeat CMR with T1 mapping as lysosomal storage dysfunction due to hydroxychloroquine lowers T1 mapping times and perhaps could be confirmed with endomyocardial biopsy.

The CMR of Case 9 can be found here: https://www.cloudcmr.com/9257–1973-8048–0166/).

11. Case 10: Rapid recurrence of a primary cardiac sarcoma assessed by CMR

11.1. Clinical history

A 24-year-old male with a history of cardiac tumor status post resection presented to the emergency department with several days of cough productive of bright red blood. He reported that the cough was constant and not associated with chest pain or palpitations. On review of systems, he only endorsed shortness of breath but otherwise denied additional constitutional, cardiovascular, or infectious complaints.

Of note, the patient reported having similar symptoms three months earlier. At that time, he presented to an outside hospital where he was found to have a large obstructive mass in the LA (Additional Movie File 20) and underwent resection. Surgical specimens were sent to pathology, which confirmed the diagnosis of undifferentiated pleomorphic sarcoma. The patient was discharged home in stable condition with follow up at our cancer institute.

Approximately one month after resection, routine TTE surveillance (Additional Movie File 21) revealed an irregularity in the posterior LA.

Further investigation with PET CT scan of the entire body and CMR was recommended by our institutional tumor board. PET CT scan (Fig. 37) revealed a low level of FDG uptake in the LA as well as intensely FDG avid lytic lesions in the left pelvis and interdigitating edema with photopenia in the right frontoparietal lobes, concerning for metastatic disease.

Fig. 37.

Fig. 37

Case 10. Fig. 1. PET CT images of the brain (A,B), mediastinum (C), and pelvis (D). There are metastatic lesions with interdigitating edema (A) with photopenia in the high right fronto-temporal lobes (B). Low level FDG uptake in the LA (C) and intensely FDG avid lesions involving the left pelvis (D) are present.

Subsequently, brain MRI with contrast (Additional Movie File 22) confirmed the presence of two solid enhancing intracranial masses.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 20, Movie 21, Movie 22..

Movie 20

Case 10 Movie 1. TTE parasternal short axis view. There is a large mass in the LA protruding through the mitral valve. A small hypoechoic area of necrosis is seen within the mass.

Download video file (2.1MB, mp4)
Movie 21

Case 10 Movie 2. TTE parasternal short axis view post-surgical resection of LA mass. There is a small area of irregularity in the posterior LA, which may represent post-surgical changes or residual mass.

Download video file (408KB, mp4)
Movie 22

Case 10 Movie 3. Brain magnetic resonance imaging sagittal view. There are two enhancing intracranial masses (arrows) due to metastasis.

Download video file (788KB, mp4)

In the emergency department, vital signs were notable for tachycardia up to 130 beats per minute. Physical examination was unremarkable, and laboratory studies revealed an elevated white blood cell count. CT scan with intravenous contrast (Fig. 38) was significant for a large hypoenhancing filling defect in the LA extending into the right upper and middle pulmonary veins. Further evaluation of the cardiac mass with TTE (Additional Movie File 23) revealed a large tumor occupying two-thirds of the LA volume.

Fig. 38.

Fig. 38

Case 10. Fig. 2. Chest CTA in the axial (A), coronal (B), and sagittal (C) planes. The LA mass (arrows) is extending into the right upper and middle pulmonary veins.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 23..

Movie 23

Case 10 Movie 4. TTE in parasternal long axis (A), parasternal short axis (B), off-axis four chamber (C), and four chamber (D) views. There is a large mass in the LA that obstructs the mitral valve (MV). Color Doppler (C,D) images show evidence of flow acceleration due to MV obstruction.

Download video file (889.9KB, mp4)

The patient was admitted to the hematology and oncology service for further evaluation and management.

11.2. CMR findings

CMR was performed at 1.5 T (Avanto, Siemens Healthineers AG, Erlangen, Germany) prior to admission, approximately two weeks after the TTE, revealed an irregularity in the posterior LA but no distinct recurrent mass. The patient was asymptomatic at the time of this initial CMR. This study delineated a large, bilobed mass with vascular components in the LA extending from the right upper pulmonary vein. On CMR, the larger lobe measured 3.1×2.8×4.2 cm and the smaller lobe measured 2.0×3.1×2.0 cm (Additional Movie File 24). Tissue characterization revealed the mass was isointense on T1-weighted imaging, hyperintense on T2w imaging, and diffusely enhancing on LGE imaging (Fig. 39, Fig. 40). The mass appeared avascular on first pass perfusion imaging (Additional Movie File 25).

Fig. 39.

Fig. 39

Case 10. Fig. 3. Four chamber (A-C) and coronal (D-F) views in T1 (A,D), T2 without fat saturation (B,E), and T2 with fat saturation (C,F) dark blood sequences. The LA mass was hypointense on T1 weighted images (A,D) and seen extending into the right pulmonary veins (arrows, A-C). The mass (arrows) was hyperintense on T2w sequences both with (C,F) and without (B,E) fat saturation.

Fig. 40.

Fig. 40

Case 10. Fig. 4. Two chamber (A,B) and four chamber (C-E) magnitude (A,C,E) and PSIR (B,D) sequences. There is heterogenous LGE of the LA mass (arrows) on sequences that null the myocardium (A-D). The high inversion time (600 msec) sequence (E) suggests evidence of some thrombus adherent to the mass (arrow).

Following urgent radiation therapy and initiation of chemotherapy, CMR was repeated during the patient's hospitalization (Additional Movie File 26). The mass now measured 8.6×3.6×4.2 cm. On this CMR, the cardiac mass was noted to prolapse though the mitral valve during diastole resulting in severe mitral valve obstruction and mild LV outflow tract obstruction.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 24, Movie 25, Movie 26..

Movie 24

Case 10 Movie 5. Cine bSSFP in four chamber stack, two chamber, and basal short axis sagittal views. There is recurrence of the large mass in the LA extending into the right pulmonary veins.

Download video file (1.5MB, mp4)
Movie 25

Case 10 Movie 6. Basal short axis first pass perfusion sequence. The LA mass appears avascular in this portion of the mass.

Download video file (200.5KB, mp4)
Movie 26

Case 10 Movie 7. Four chamber stack cine bSSFP images. There is a large LA mass prolapsing across the mitral valve.

Download video file (680.8KB, mp4)

11.3. Conclusion

Both CMRs revealed a large, obstructive LA mass in a patient with a known history of undifferentiated pleomorphic sarcoma. Recurrence of the sarcoma, with rapid growth over a three-week period likely precipitated the patient’s presentation. His hospital course was complicated by acute hypoxic respiratory failure secondary to obstructive mass effect resulting in pulmonary edema and post-obstructive pneumonia. The patient was not a surgical candidate and underwent urgent palliative chemotherapy and radiation therapy. One month after being admitted he was discharged home in stable condition. He continues palliative chemotherapy as an outpatient and his symptoms are well controlled.

11.4. Perspective

Primary cardiac tumors are rare with a prevalence between 0.002% and 0.03% [87]. Among these tumors, approximately one quarter are malignant, with sarcomas being the most common [88]. Undifferentiated pleomorphic sarcoma, also referred to as malignant fibrous histiocytoma and undifferentiated sarcoma, account for one third of cardiac sarcomas [89]. Most undifferentiated pleomorphic sarcomas of the heart typically originate in the LA, as in our case, but are locally aggressive and prone to metastasize [90]. As a result, outcomes are poor[91], [92], [93]. The standard of care involves resection with adjuvant chemotherapy and/or radiation therapy [92]. Complete resection followed by adjuvant medical therapy offers the best outcomes. However, clear surgical margins are difficult to obtain, and recurrence remains a challenge [94], [95], [96], [97]. Recurrence in our patient is noteworthy for the rapid rate of re-growth resulting in clinically significant obstruction during the two-week period between the TTE and CMR.

The utility of CMR in the work-up of cardiac masses is well established [98]. In particular, the unique ability to discriminate differences in tissue densities and the resulting signal patterns on T1w- and T2w techniques can often help narrow the differential. Undifferentiated sarcomas of the heart are classically isointense on T1w imaging, hyperintense on T2w imaging, and heterogenous on LGE imaging [98], [99]. Consistent with these characteristics, the tumor in our patient was isointense on T1w imaging, hyperintense on T2w imaging, and diffusely enhancing on LGE imaging. Thus, in addition to the patient history, the CMR with signal pattern consistent with sarcoma as well as the rapid interval increase in size assessed by CMR all supported the diagnosis of recurrent undifferentiated pleomorphic sarcoma complicated by obstructive mass effect.

The CMR examinations of Case 10 can be found here: Study 1, https://www.cloudcmr.com/0157–1973-5348–0167/, Study 2, https://www.cloudcmr.com/6357–1973-9048–0145/).

12. Case 11: Simultaneous occurrence of myocardial infarction and broken heart syndrome

12.1. Clinical history

This 89-year-old grandmother with a history of hypertension, diabetes, dyslipidemia, and severe polyneuropathy with unsteady gait and frequently falls had a fall with severe facial laceration. The next day, she complained of weakness and shortness of breath.

A few days prior to the fall, she was diagnosed with new rapid atrial fibrillation and treated with a beta-blocker. She spontaneously converted into sinus rhythm but atrial fibrillation recurred and she was started on apixaban and amiodarone.

Four days after her fall, she reported chest pressure. ECG showed R-wave loss and ST-segment elevations over the anterior leads (Fig. 41). High sensitivity troponin (0.519 ng/ml, normal range <0.014 ng/ml), and BNP were markedly elevated (6233 ng/l, normal range <100 ng/ml). Urgent coronary angiography revealed a 95% stenosis of the mid LAD (segment 7) (Fig. 42), treated with two drug eluting stents.

Fig. 41.

Fig. 41

Case 11. Fig. 1. 12-lead ECG on admission. The ECG shows low voltage, R-wave reduction and ST-segment elevation in leads V2-V5 indicating acute myocardial injury.

Fig. 42.

Fig. 42

Case 11. Fig. 2. Coronary angiogram anteroposterior projection. There is subtotal occlusion of the LAD (arrows).

TTE showed impaired LV systolic function with severe hypokinesis/akinesis of all mid/distal and apical segments. Basal segment contractility was preserved. These findings were suggestive of Takotsubo cardiomyopathy ("broken heart syndrome"). To evaluate the likelihood of improvement of LV function and recovery of the wall motion abnormalities, a contrast-enhanced CMR was performed.

12.2. CMR findings

3 T CMR (Magnetom Skyra, Siemens Healthineers AG, Erlangen, Germany) performed the second day of admission showed highly impaired LV function with myocardial thinning and akinesis/dyskinesis of all mid/distal and apical LV segments (Additional Movie File 27). T2 turbo spin echo imaging revealed global edema of the mid/distal segments (Fig. 43). LGE revealed a small MI limited to the distal septal and distal anterior segments (Fig. 44). Global RVEF was preserved (RVEF = 67%) despite distal free wall hypokinesis. There were no significant valvular abnormalities. There were bilateral pleural effusions. ECG performed two days later showed resolution of ST-segment elevation (Fig. 45).

Fig. 43.

Fig. 43

Case 11. Fig. 3. Pre-contrast T2w turbo spin echo images in apical (A), mid (B), basal (C) short-axis orientation. Increased signal intensity of the myocardium in the apical and mid segments indicates myocardial edema, and the basal segments are unaffected.

Fig. 44.

Fig. 44

Case 11. Fig. 4. Post-contrast PSIR images in two chamber (A), three chamber (B), four chamber (C), and mid short-axis (D) orientations. There is a mild sub-endocardial LGE of the distal septal and apical segments.

Fig. 45.

Fig. 45

Case 11. Fig. 5. 12-lead ECG two days after presentation. Q-waves have developed in the anterior leads and ST-segment elevation has largely resolved.

Three months later, a follow-up CMR revealed mild residual hypokinesis of the distal septum and apex with normal global systolic function (LVEF 59%) and recovered wall thickness (Additional Movie File 28 and Fig. 46). The distal RV free wall contracted normally. The limited distal septal and apical MI was better visualized. An ECG demonstrated R-wave recovery of the anterior wall (Fig. 47). Three months later, after GDMT she felt much better and no longer complained of dyspnea or chest pain [105], [106].

Fig. 46.

Fig. 46

Case 11. Fig. 6. Post-contrast PSIR image in four chamber orientation. Mild sub-endocardial LGE of the distal septal and apical segments persists.

Fig. 47.

Fig. 47

Case 11. Fig. 7. 12-lead ECG three months after presentation. There is recovery of R-wave amplitude in the anterior leads.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 27, Movie 28..

Movie 27

Case 11 Movie 1. Cine bSSFP imaging in two chamber (A), three chamber (B), four chamber (C), and mid short-axis (D) orientations. There is akinesis/dyskinesis of all mid and distal LV segments with basal segments hyperkinetic. Bilateral pleural effusions (A-C) are present.

Download video file (252KB, mp4)
Movie 28

Case 11 Movie 2. Cine bSSFP images in two chamber (A), three chamber (B), four chamber (C), and mid short-axis (D) orientations. LV systolic function has normalized.

Download video file (167.1KB, mp4)

12.3. Conclusion

This case highlights the importance of CMR in the diagnosis and prognosis of heart failure in a rare case of simultaneous occurrence of MI and Takotsubo cardiomyopathy[100], [101]. Whether the initial ST-segment elevations were due to a ST-segment elevation MI or Takotsubo cardiomyopathy remains unclear. TTE revealed severe LV dysfunction but could not clearly discriminate between these two diagnoses. Tachycardia-induced cardiomyopathy could also have been a contributing factor to the initially severely reduced LVEF.

12.4. Perspective

CMR showed typical wall motion abnormalities in accordance with stress-induced Takotsubo cardiomyopathy despite the discovery of a small LAD-territory MI. Myocardial viability of most hypokinetic segments was proven by contrast enhanced CMR. Hypokinesis and myocardial edema involved all mid/distal LV segments including the mid inferior and inferolateral segments that are not typically within the mid-LAD territory. Global edema of mid/distal LV segments has been reported in Takotsubo cardiomyopathy[102]. Thus, in this case, regional hypokinesis was not solely due to myocardial stunning from epicardial coronary ischemia. Improvement of systolic function was predicted by the original CMR and proven by the follow-up study[103]. CMR was crucial to resolve the differential diagnosis and helped to explore the different causes of diseases leading to severe acute heart failure[104].

As it is rare that two diseases (MI and takotsubo cardiomyopathy) which can singularly cause heart failure simultaneously occur and CMR accurately predicted the ventricular recovery.

The CMR examinations of of Case 11 can be found here:, Study 1, https://www.cloudcmr.com/0157–1973-4408–0116/, Study 2, https://www.cloudcmr.com/2657–1973-9668–0148/).

13. Case 12: Utility of CMR in confirming spontaneous coronary artery dissection

13.1. Clinical history

A 62-year-old female with a history of hypertension and hyperlipidemia presented with a one day history of recurrent episodes of sudden onset, mid-sternal chest pain radiating to the neck and upper back while at rest. On exam, the patient was noted to be hypertensive to 187/98 mmHg and tachycardic to 103 bpm with no other remarkable finding. Serial high-sensitivity troponins trended upward from < 4 ng/L to 23,121 ng/L (normal ≤ 17 ng/L). Other lab values were within normal range. A 12-lead ECG demonstrated an incomplete RBBB with T-wave inversions in the anterior leads (Fig. 48).

Fig. 48.

Fig. 48

Case 12. Fig. 1. Presenting 12-lead ECG. There is incomplete right bundle branch block with T-wave inversion in the anterior leads.

Due to concern for a non-ST-elevation myocardial infarction (NSTEMI), the patient was taken for coronary angiography, which revealed tapering of the superior branch of the first obtuse marginal coronary artery, concerning for spontaneous coronary artery dissection (SCAD) (Fig. 49 and Additional Movie File 29). There was no other evidence of obstructive CAD. Left ventriculogram from right anterior oblique angle demonstrated severe hypokinesis of the mid-anterior wall. TTE revealed an LVEF of 55% with focal area of moderate hypokinesis at the mid to distal inferolateral and anterolateral walls (Additional Movie File 30). LVEDV was 61.5 ml (LVEDVI 34 ml/m2) and LVESV was 22.8 ml (LVESVI 13 ml/m2).

Fig. 49.

Fig. 49

Case 12. Fig. 2. Coronary angiogram in anteroposterior projection. There is an abrupt tapering (arrow) of the obtuse marginal 1 branch of the left circumflex, concerning for spontaneous coronary artery dissection.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 29, Movie 30..

Movie 29

Case 12 Movie 1. Coronary angiogram in anteroposterior projection. There is an abrupt tapering of the obtuse marginal 1 branch of the left circumflex, concerning for spontaneous coronary artery dissection.

Download video file (1.1MB, mp4)
Movie 30

Case 12 Movie 2. TTE with contrast apical three chamber (A) and four chamber (B) views. There is hypokinesia of the mid to distal inferolateral and anterolateral walls.

Download video file (1.5MB, mp4)

13.2. CMR findings

As the area of regional wall motion abnormality did not correlate with the coronary distribution of the SCAD vessel and there was discrepancy between the wall motion abnormality noted on the coronary angiogram and that noted on the TTE, further evaluation was performed using a CMR. CMR was performed on a 1.5 T CMR system (Optima MR 450w, General Electric HealthCare, Chicago, Illinois, USA). Cine bSSFP images were used to evaluate LV morphology and function. Tissue imaging was performed using double and triple inversion recovery sequences. Standard first pass perfusion and LGE imaging was performed.

The patient was found to have a normal LV size (LVEDVI 64 ml/m2, normal 52–86 ml/m2) with an LVEF of 51%. There was focal mid to distal inferolateral and anterolateral wall severe hypokinesis, sparing the apex (Additional Movie File 31). Also in this area, there was edema with subendocardial to near transmural LGE (Fig. 50). Lateral subendocardial perfusion defect was also noted on resting first pass perfusion imaging (Additional Movie File 32 and Fig. 51). There is evidence of a small area of microvascular obstruction (MVO) as well (Fig. 52). Patient otherwise had normal size and systolic function of the RV with a normal pericardium.

Fig. 50.

Fig. 50

Case 12. Fig. 3. Four chamber (A) and three chamber (B) T2w double inversion recovery sequences. There is sub-endocardial hyperenhancement of the mid to distal anterolateral walls (arrows) indicating edema.

Fig. 51.

Fig. 51

Case 12. Fig. 4. Apical short axis rest first pass perfusion. There is a sub-endocardial rest perfusion defect in the apical LV lateral wall (arrow).

Fig. 52.

Fig. 52

Case 12. Fig. 5. Four chamber (A) and three chamber (B) LGE images. There is sub-endocardial LGE with pockets of microvascular obstruction (arrows) in the mid to apical anterolateral and inferolateral walls.

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 31, Movie 32..

Movie 31

Case 12 Movie 3. Cine bSSFP images in four chamber (A) and short axis stack (B). There is focal akinesia in the lateral apical LV wall.

Download video file (1.3MB, mp4)
Movie 32

Case 12 Movie 4. Apical short axis rest first pass perfusion. There is a sub-endocardial rest perfusion defect in the apical LV lateral wall.

Download video file (342.7KB, mp4)

13.3. Conclusion

The CMR findings were suggestive of focal, near transmural acute MI consistent with first obtuse marginal SCAD in the setting of the clinical history and recent coronary angiogram findings. While focal myocarditis and infiltrative cardiomyopathy can also look similar on CMR, they are less likely in this scenario. Thus, the patient was managed with dual antiplatelet therapy, beta-blocker, and appropriate lipid-lowering agents. On a follow-up clinic visit, she was chest pain free without residual ischemic symptoms.

13.4. Perspective

In women, SCAD is an important cause of acute MI and sudden cardiac arrest; however, it can often be misdiagnosed, or go undiagnosed, due to inherent limitations in current coronary angiogram techniques[107]. While use of optical coherence tomography and intravascular ultrasound can help better visualize the arterial wall, such instrumentation can lead to worsening of dissection and will not help determine the extent of the myocardial damage[108]. Furthermore, the severity of ischemia/infarction associated with SCAD is highly variable and the majority of patients have a small-sized MI with preserved LVEF[109].

Knowledge of the pathophysiology of MI due to epicardial occlusion is essential to the understanding of SCAD-associated CMR findings. Initially, the myocardial necrosis progresses from the sub-endocardium towards the epicardium[110]. Then, the degree of revascularization achieved spontaneously or via percutaneous coronary intervention leads to various levels of reperfusion injury that is reflected by edema and MVO. MVO is the pathologic correlation of the no-reflow phenomenon usually after delayed recanalization and has multiple causative mechanisms (primary endothelial destruction, extravascular compression from interstitial edema, vasoconstriction induced by mediators released by the culprit lesion, obstruction by embolized debris, in-situ platelet aggregation)[111].

Gadolinium is an extracellular contrast agent and persists longer in the areas of disrupted necrotic myocardial cells, allowing for measurement of the infarct size with the T1w images in both early and late post-MI period. Expert consensus recommends CMR for LGE extent to be done approximately 5 days after the event to minimize confounding from the initial dynamic infarct and associated edema[112]. MVO will appear as a hypointense core within the hyperintense infarct zone within the area of LGE reflecting the failure of the contrast agent to penetrate the infarct core. These markers have been well established in the assessment of atherosclerotic MI and only recently applied to the evaluation of SCAD cases. Two recent studies demonstrated how CMR was valuable in confirming SCAD as the cause of acute MI by demonstrating evidence of necrosis in a particular vessel territory, hence ruling out other causes like Takotsubo cardiomyopathy and myocarditis[108], [113]. In general, CMR is essential in the work-up for and diagnosis of various causes of myocardial infarction with non-obstructive coronary arteries (MINOCA) due to its superior ability to characterize the myocardium, safety, accuracy, and inter-observer consistency.

Our case adds to the list of CMR-confirmed SCAD cases and demonstrates how CMR is an important tool for the diagnosis in the setting of acute coronary syndrome-like presentation but with discrepant angiographic findings. Early and appropriate diagnosis allows for initiation of optimal medical therapy as well as for potential prognostic assessment by evaluation of microvascular obstruction.

The CMR of Case 12 can be found here: https://www.cloudcmr.com/2957–1973-2128–0128/).

14. Case 13: Pericardial hydatid cyst with pericoronary involvement and large pericardial effusion

14.1. Clinical history

A 54-year-old male, presented to the cardiology clinic with progressive increasing shortness of breath over the last 4 months (New York Heart Association (NYHA) class III). He did not complain of chest pain or palpitations. No systemic symptoms like fever or weight loss were present. The rest of his past medical history was negative.

A chest X-ray was concerning for a pericardial effusion (Fig. 53). TTE was done, that confirmed the presence of pericardial effusion, however, additionally raised the possibility of a cystic lesion in the pericardium with possible coronary involvement. The ventricular function was normal (reported LVEF 55%).

Fig. 53.

Fig. 53

Case 13. Fig. 1. Chest x-ray anteroposterior projection. There is mediastinal widening concerning for a pericardial effusion.

Coronary CTA with larger field of view was done to evaluate the cystic lesion, possible coronary artery involvement that showed a large pericardial effusion and mild pericardial calcification (Fig. 54). A multiloculated cystic lesion with enhancing septations within it was noted in close proximity to basal to mid lateral LV wall, however no intramyocardial extension was seen. The lesion was encasing the left main coronary artery and proximal portions of LAD and LCx coronary arteries with mild narrowing of the LCx (Fig. 54). Possibility of Hydatid cyst was suggested based on this honeycomb pattern, and CMR was ordered for further evaluation and to better characterize the cystic mass.

Fig. 54.

Fig. 54

Case 13. Fig. 2. Chest CTA with contrast in axial (A,B) and coronal (C) slices. There is a multiloculated cystic lesion with enhanced septations encasing the LAD and left circumflex coronary arteries (arrow).

14.2. CMR findings

CMR performed a 3 T (Ingenia, Philips Healthcare, Best, Netherlands) demonstrated a large pericardial effusion showing heterogeneous signals on cine bSSFP images (Additional Movie File 33). Mild pericardial thickening was also seen. There was no pericardial LGE.

Well defined multiloculated cystic lesion was noted in close proximity to mid lateral LV wall (Additional Movie File 33). The lesion was also extending posterior to the aortic root/ascending aorta, inferior to the main pulmonary artery and antero-superior to the LAA. The lesion was multivesicular, with daughter cysts with honeycomb like appearance, suggesting cystic echinococcosis (CE)-2 (World Health Organization (WHO) Classification Informal Working Group on Echinococcosis (IWGE)) active stage (Additional Movie File 33). The cystic lesions were isointense on bSSFP and T1w imaging, hyperintense on T2w imaging, and hypointense on perfusion with contrast and LGE (Fig. 55).

Fig. 55.

Fig. 55

Case 13. Fig. 3. Mid short axis cine balanced steady state free precession (bSSFP) (A), T1w (B), T2w (C), first pass perfusion (D), and PSIR post contrast (E) slices. The cyst (*) is isointense on bSSFP, T1w, hyperintense on T2w imaging, and hypointense on perfusion with contrast and PSIR LGE imaging.

LV was normal in size with mildly reduced systolic function (LVEF 48%) and hypokinesis of the mid lateral LV with decreased perfusion and near transmural enhancement on LGE images was noted suggesting scar in LCx distribution (Additional Movie File 34 and Fig. 56). Although this corresponds to the LCx distribution, the scar is more likely due to inflammation and scarring from hydatid cyst. The possibility of transmural ischemic scar is unlikely due to non-critical LCx artery narrowing. The RV was normal in size, systolic function, and no RV scar was seen. Abdominal ultrasound was negative for intraabdominal cysts. The patient was advised to proceed with surgical resection due to the risk of cyst rupture, but he opted for medical treatment with albendazole. A follow up imaging was suggested, however patient was lost to follow up.

Fig. 56.

Fig. 56

Case 13. Fig. 4. Mid short axis PSIR post contrast. There is near transmural LGE of the mid lateral LV wall (arrow).

Supplementary material related to this article can be found online at doi:10.1016/j.jocmr.2023.100007.

The following is the Supplementary material related to this article Movie 33, Movie 34..

Movie 33

Case 13 Movie 1. Four chamber cine bSSFP images. There is a large pericardial effusion, multiloculated cystic lesion along the lateral LV wall, extending posterior to the aortic root, ascending aorta, inferior to the main pulmonary artery and anterior to the LA appendage.

Download video file (185.5KB, mp4)
Movie 34

Case 13 Movie 2. Mid short axis cine bSSFP (A) and rest perfusion (B) slices. There is hypokinesia of the mid lateral LV wall with decreased perfusion.

Download video file (889.4KB, mp4)

14.3. Conclusion

CMR allowed for better characterization of the cyst, as well identified the associated LV wall motion abnormality and scar. Diagnosis of pericardial hydatid cyst with pericoronary involvement (CE-2 WHO Classification IWGE suggestive of active stage) and large pericardial effusion was made. Enzyme-linked immunoassay for echinococcus (IgG antibodies) done after CMR examination was positive.

14.4. Perspective

Cardiac hydatid disease is a rare manifestation of echinococcus infection. It represents 0.5 to 2% of hydatic disease[114]. The most common location is the LV myocardium followed by the RV, pericardium, pulmonary artery, interventricular septum, the LA, the RA, and interatrial septum. Hydatid disease in endemic in many parts of world, including India. The annual incidence in India varies from 1 to 200 per 100000 population[115]. Dogs and cats are primary carriers of this parasite. Humans can be infected as an intermediary carrier when they eat unwashed or uncooked vegetables or swallow the parasite eggs. The clinical presentation may vary from asymptomatic cases to fever, chest pain, dyspnea on exertion and anaphylactic shock due to cyst rupture. Less likely complications like systemic or pulmonary hydatid embolism, valve obstruction, papillary muscle involvement with secondary mitral regurgitation, and invasion into the conduction system with arrhythmias have also been described.

Diagnosis can be made using imaging and serology. The presence of a uni- or multivesicular cyst, with a honeycomb appearance is characteristic of the echinococcal cyst. The WHO-IWGE developed an international ultrasound classification. According to this classification, cysts pass through CE1 (active) through CE5 (inactive) phases [116]. The hydatid serology was positive in our patient and often positive in the literature, but its negativity does not eliminate the diagnosis [117].

Surgery is the treatment of choice for cardiac hydatid cysts, however in some cases medical treatment is advocated. These include small or calcified cysts, in elderly patients, or when surgery is contraindicated or refused by the patient; as in our case. Pericardium is an unusual location of hydatid disease, and it needs to be considered in the differential diagnosis of pericardial effusion especially if there is a prior history of hydatid disease, a contact with animals, and in endemic countries.

The CMR of Case 13 can be found here: https://www.cloudcmr.com/4057–1973-8088–0155/).

Ethics approval and consent to participate

Ethics approval and consent to participate were obtained by the authors from each institute.

Authors’ contributions

All authors have contributed either in manuscript writing or by intellectual supervision to this review.

Consent for publication

Consent for publication was obtained.

Funding

Not applicable.

CRediT authorship contribution statement

Kikuchi Daniel S: Writing – original draft. Goulbourne Clive A: Writing – original draft. Sahu Anurag: Writing – original draft. Dzelebdzic Sanja: Writing – original draft. Sievers Berge: Writing – original draft. Sievers Berk: Writing – original draft. Muniz Juan Carlos: Writing – original draft. Sievers Burkhard: Writing – original draft. Lee Marc: Writing – original draft. Garg Rimmy: Writing – original draft. Armas Carlos Requena: Writing – original draft. Williams Jason: Writing – original draft. Paleru Vijayasree: Writing – original draft. Agarwal Ritu: Writing – original draft. Lee Simon: Writing – original draft. Johnson Jason Nathaniel: Conceptualization, Data curation, Project administration, Supervision, Visualization, Writing – original draft, Writing – review & editing. Pouraliakbar Hamidreza: Writing – original draft. Aggarwal Sachin K: Writing – original draft. Mahdavi Mohammad: Writing – original draft. Ranjbar Abdolmohammad: Writing – original draft. Pfirman Kristopher: Writing – original draft. Rajagopal Rengarajan: Writing – original draft. Bhagirath Pranav: Visualization, Writing – original draft, Writing – review & editing. Kozor Rebecca: Visualization, Writing – original draft, Writing – review & editing. Clark Daniel E: Writing – original draft. Aneja Ashish: Visualization, Writing – original draft, Writing – review & editing. Tunks Bobby: Visualization, Writing – original draft, Writing – review & editing. Hughes Sean G: Writing – original draft. Mehra Vishal: Writing – original draft. Ahmed Shahzad: Writing – original draft. Chen Sylvia S.M.: Conceptualization, Visualization, Writing – original draft, Writing – review & editing. Ganigara Madhusudan: Writing – original draft. Ba-Atiyah Wejdan: Writing – original draft. Nagiub Mohamed: Writing – original draft. Hussain Tarique: Writing – original draft. Galal Mohammed Omar: Writing – original draft. Kwok Cecilia: Writing – original draft. Zahr Riad Abou: Writing – original draft. Lim Han S: Writing – original draft. Hussain Nasir: Writing – original draft. Nolan Mark: Writing – original draft. Tadikamalla Raghu R: Writing – original draft. Farah Victor: Writing – original draft.

Competing interests

There are no competing interests.

Acknowledgements

We would like to thank Dr. Seyyed-Reza Sadat-Ebrahimi for assistance with Case 1. We wish to thank Dr. Simon Bodek, Clinical Geneticist at Austin Health in Melbourne, Australia for his valuable contribution to Case 9. We would like to thank the Cases of SCMR reviewers for their hard work and dedication to timely reviews of the submitted cases.

Cases of SCMR prepared by

Ashish Aneja.

Associate Editor, Cases of SCMR.

Case Western Reserve University School of Medicine.

Pranav Bhagirath.

Associate Editor, Cases of SCMR.

St. Thomas Hospital.

Sylvia S.M. Chen, MD.

Editor-in-Chief, Cases of SCMR.

The Prince Charles Hospital.

Madhusudan Ganigara.

Associate Editor, Cases of SCMR.

The University of Chicago & Biological Sciences.

Sean G. Hughes, MD.

Associate Editor, Cases of SCMR.

Vanderbilt University Medical Center.

Jason N. Johnson, MD MHS.

Deputy Editor, Cases of SCMR.

Le Bonheur Children’s Hospital, University of Tennessee Health Science Center.

Rebecca Kozor.

Associate Editor, Cases of SCMR.

The University of Sydney.

Robert Tunks.

Associate Editor, Cases of SCMR.

Penn State Health.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Data Availability

All data generated or analyzed during this study are included in this published article [and its supplementary information files].

References

  • 1.Dahiya A., Chao C., Younger J., Kar J., Baldwin B.M., Cohen M.V., et al. Society for Cardiovascular Magnetic Resonance 2019 case of the week series. J Cardiovasc Magn Reson. 2021;23(1) doi: 10.1186/s12968-020-00671-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Johnson J.N., Mandell J.G., Christopher A., Olivieri L.J., Loke Y.H., Campbell M.J., et al. Society for Cardiovascular Magnetic Resonance 2020 case of the week series. J Cardiovasc Magn Reson. 2021;23(1) doi: 10.1186/s12968-021-00799-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Johnson J.N., Loriaux D.B., Jenista E., Kim H.W., Baritussio A., De Garate Iparraguirre E., et al. Society for Cardiovascular Magnetic Resonance 2021 cases of SCMR and COVID-19 case collection series. J Cardiovasc Magn Reson. 2022;24(1) doi: 10.1186/s12968-022-00872-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bellino S., Punzo O., Rota M.C., Del Manso M., Urdiales A.M., Andrianou X., et al. COVID-19 disease severity risk factors for pediatric patients in Italy. Pediatrics. 2020;146(4) doi: 10.1542/peds.2020-009399. [DOI] [PubMed] [Google Scholar]
  • 5.Molaei A., Sadeghi-Shabestari M., Khomahani A., Ghaffari S., Sadat-Ebrahimi S.-R. Cardiac Biomarkers for early detection of cardiac involvement in children with Kawasaki disease: A cross-sectional study. International Journal of Pediatrics. 2019;7(12):10573–10582. [Google Scholar]
  • 6.Sadat-Ebrahimi S.-R. Diagnostic and prognostic value of cardiac biomarkers in children with Kawasaki disease: A state-of-the-art review. Int J Pediatr. 2020;8(2):10911–10928. [Google Scholar]
  • 7.Newburger J.W., Takahashi M., Burns J.C. Kawasaki disease. J Am Coll Cardiol. 2016;67(14):1738–1749. doi: 10.1016/j.jacc.2015.12.073. [DOI] [PubMed] [Google Scholar]
  • 8.Sarzaeim M., Rezaei N. Kawasaki disease and multisystem inflammatory syndrome in children with COVID-19. SN Compr Clin Med. 2020;2(11):2096–2101. doi: 10.1007/s42399-020-00558-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Toubiana J., Poirault C., Corsia A., Bajolle F., Fourgeaud J., Angoulvant F., et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. Bmj. 2020;369:m2094. doi: 10.1136/bmj.m2094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Akca U.K., Kesici S., Ozsurekci Y., Aykan H.H., Batu E.D., Atalay E., et al. Kawasaki-like disease in children with COVID-19. Rheumatol Int. 2020;40(12):2105–2115. doi: 10.1007/s00296-020-04701-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Merlocco A., Philip R., Beasley G., Ryan K., Shah S., Sathanandam S., et al. Myocardial infarction at mid-term follow-up in a teenager with multisystem inflammatory syndrome in children after COVID-19. Circ Cardiovasc Imaging. 2022;15(5) doi: 10.1161/CIRCIMAGING.122.014010. [DOI] [PubMed] [Google Scholar]
  • 12.Ng M.Y., Ferreira V.M., Leung S.T., Yin Lee J.C., Ho-Tung Fong A., To Liu R.W., et al. Patients recovered from covid-19 show ongoing subclinical myocarditis as revealed by cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2476–2478. doi: 10.1016/j.jcmg.2020.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265–1273. doi: 10.1001/jamacardio.2020.3557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.WHO. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 2020 [Available from: 〈https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19〉.
  • 15.Rajpal S., Tong M.S., Borchers J., Zareba K.M., Obarski T.P., Simonetti O.P., et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 Infection. JAMA Cardiol. 2021;6(1):116–118. doi: 10.1001/jamacardio.2020.4916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Webster G., Patel A.B., Carr M.R., Rigsby C.K., Rychlik K., Rowley A.H., et al. Cardiovascular magnetic resonance imaging in children after recovery from symptomatic COVID-19 or MIS-C: a prospective study. J Cardiovasc Magn Reson. 2021;23(1) doi: 10.1186/s12968-021-00786-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Barris D.M., Keelan J., Ahluwalia N., Jhaveri S., Cohen J., Stern K., et al. Midterm outcomes and cardiac magnetic resonance imaging following multisystem inflammatory syndrome in children. J Pediatr. 2022;241:237–241.e1. doi: 10.1016/j.jpeds.2021.10.009. [DOI] [PubMed] [Google Scholar]
  • 18.Blondiaux E., Parisot P., Redheuil A., Tzaroukian L., Levy Y., Sileo C., et al. Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19. Radiology. 2020;297(3):E283–E288. doi: 10.1148/radiol.2020202288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dietz S.M., Tacke C.E., Kuipers I.M., Wiegman A., de Winter R.J., Burns J.C., et al. Cardiovascular imaging in children and adults following Kawasaki disease. Insights Imaging. 2015;6(6):697–705. doi: 10.1007/s13244-015-0422-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Greil G.F., Stuber M., Botnar R.M., Kissinger K.V., Geva T., Newburger J.W., et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation. 2002;105(8):908–911. doi: 10.1161/hc0802.105563. [DOI] [PubMed] [Google Scholar]
  • 21.Goo H.W., Park I.S., Ko J.K., Kim Y.H. Coronary CT angiography and MR angiography of Kawasaki disease. Pediatr Radiol. 2006;36(7):697–705. doi: 10.1007/s00247-006-0182-6. [DOI] [PubMed] [Google Scholar]
  • 22.Basso C., Buser P., Rizzo S., Lombardi M. In: The EACVI Textbook of Cardiovascular Magnetic Resonance. Lombardi M., Plein S., Petersen S.E., Bucciarelli-Ducci C., Valsangiacomo-Buechel E., Basso C., et al., editors. Oxford University Press; Oxford: 2018. Metastatic tumours; pp. 463–483. [Google Scholar]
  • 23.Kassi M., Polsani V., Schutt R.C., Wong S., Nabi F., Reardon M.J., et al. Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging. J Thorac Cardiovasc Surg. 2019;157(5):1912–1922.e2. doi: 10.1016/j.jtcvs.2018.09.057. [DOI] [PubMed] [Google Scholar]
  • 24.Villa A., Eshja E., Dallavalle S., Bassi E.M., Turco A. Cardiac metastases of melanoma as first manifestation of the disease. J Radiol Case Rep. 2014;8(4):8–15. doi: 10.3941/jrcr.v8i4.1700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi: 10.3322/caac.21654. [DOI] [PubMed] [Google Scholar]
  • 26.Sandru A., Voinea S., Panaitescu E., Blidaru A. Survival rates of patients with metastatic malignant melanoma. J Med Life. 2014;7(4):572–576. [PMC free article] [PubMed] [Google Scholar]
  • 27.Buechel E.V., Kaiser T., Jackson C., Schmitz A., Kellenberger C.J. Normal right- and left ventricular volumes and myocardial mass in children measured by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2009;11(1) doi: 10.1186/1532-429X-11-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yasukochi S., Satomi G., Park I., Ando M., Momma K. Unguarded mitral orifice, mirror-imaged atrial arrangement, and discordant atrioventricular connections. Cardiol Young. 1999;9(5):478–483. doi: 10.1017/s1047951100005382. [DOI] [PubMed] [Google Scholar]
  • 29.Earing M.G., Edwards W.D., Puga F.J., Cabalka A.K. Unguarded mitral orifice associated with discordant atrioventricular connection, double-outlet right ventricle, and pulmonary atresia. Pediatr Cardiol. 2003;24(5):490–492. doi: 10.1007/s00246-002-0389-8. [DOI] [PubMed] [Google Scholar]
  • 30.Wenink A.C., Gittenberger-de Groot A.C., Brom A.G. Developmental considerations of mitral valve anomalies. Int J Cardiol. 1986;11(1):85–101. doi: 10.1016/0167-5273(86)90202-0. [DOI] [PubMed] [Google Scholar]
  • 31.Howley L.W., Strasburger J., Maleszewski J.J., Snowise S., Lund A., Schneider A., et al. Fetal unguarded mitral valve orifice, aortic atresia, and severe left heart enlargement. JACC Case Rep. 2021;3(2):206–211. doi: 10.1016/j.jaccas.2020.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hwang M.S., Chang Y.S., Chu J.J., Lin W.S., Su W.J. A potential new constellation of defects: unguarded mitral orifice associated with double-outlet right ventricle {I, D, D} and pulmonary atresia/stenosis. Int J Cardiol. 2011;148(3):354–357. doi: 10.1016/j.ijcard.2010.06.004. [DOI] [PubMed] [Google Scholar]
  • 33.Subramanian A., Bharath A.P., Jayaranganath M. Unguarded left atrioventricular orifice: an unusual cause of hypoplastic left ventricle and double-outlet right ventricle with intact ventricular septum. Ann Pediatr Cardiol. 2019;12(2):153–155. doi: 10.4103/apc.APC_124_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kishi K., Katayama H., Ozaki N., Odanaka Y., Masuda M., Nemoto S., et al. Fatal cardiac anomaly of unguarded mitral orifice with asplenia syndrome. J Cardiol Cases. 2017;15(1):6–9. doi: 10.1016/j.jccase.2016.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Shati A., Shati A., Alakhfash A., Al Mesned A., Al-Halees Z.Y. 65. A female neonate with unguarded mitral valve orifice. Journal of the Saudi Heart Association. 2015;27(4):324. [Google Scholar]
  • 36.Su J.A., Ho J., Wong P.C. Unguarded mitral orifice associated with hypoplastic left heart syndrome. Cardiol Young. 2015;25(5):1002–1005. doi: 10.1017/S1047951114001334. [DOI] [PubMed] [Google Scholar]
  • 37.Banerji N., Krishna M.R., Kumar R.K., Anderson R.H. Caught-off guard: Unguarded mitral valve orifice in usual atrial arrangement with discordant atrioventricular connections and pulmonary atresia. Ann Pediatr Cardiol. 2020;13(1):84–86. doi: 10.4103/apc.APC_4_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Romagnoli A., Ricci A., Morosetti D., Fusco A., Citraro D., Simonetti G. Congenital left ventricular diverticulum: multimodality imaging evaluation and literature review. J Saudi Heart Assoc. 2015;27(1):61–67. doi: 10.1016/j.jsha.2014.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sherif H.M., Maniar H.S., Spadea N., Marge M., Banbury M.K. Left ventricular diverticulum mimicking ventricular pseudoaneurysm in an adult. Tex Heart Inst J. 2010;37(5):584–586. [PMC free article] [PubMed] [Google Scholar]
  • 40.Aquaro G.D., Di Bella G., Strata E., Deiana M., De Marchi D., Pingitore A., et al. Cardiac magnetic resonance findings in isolated congenital left ventricular diverticuli. Int J Cardiovasc Imaging. 2007;23(1):43–47. doi: 10.1007/s10554-006-9120-9. [DOI] [PubMed] [Google Scholar]
  • 41.Walton-Shirley M., Smith S.M., Talley J.D. Left ventricular diverticulum: case report and review of the literature. Cathet Cardiovasc Diagn. 1992;26(1):31–33. doi: 10.1002/ccd.1810260108. [DOI] [PubMed] [Google Scholar]
  • 42.Archbold R.A., Robinson N.M., Mills P.G. Long-term follow-up of a true contractile left ventricular diverticulum. Am J Cardiol. 1999;83(5):810–813. doi: 10.1016/s0002-9149(98)01003-0. a11. [DOI] [PubMed] [Google Scholar]
  • 43.Kawel-Boehm N., Hetzel S.J., Ambale-Venkatesh B., Captur G., Francois C.J., Jerosch-Herold M., et al. Correction to: reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson. 2021;23(1) doi: 10.1186/s12968-021-00815-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Dionne A., Sperotto F., Chamberlain S., Baker A.L., Powell A.J., Prakash A., et al. Association of myocarditis With BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021;6(12):1446–1450. doi: 10.1001/jamacardio.2021.3471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Shiyovich A., Witberg G., Aviv Y., Eisen A., Orvin K., Wiessman M., et al. Myocarditis following COVID-19 vaccination: magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. 2022;23(8):1075–1082. doi: 10.1093/ehjci/jeab230. [DOI] [PubMed] [Google Scholar]
  • 46.Kim H.W., Jenista E.R., Wendell D.C., Azevedo C.F., Campbell M.J., Darty S.N., et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;6(10):1196–1201. doi: 10.1001/jamacardio.2021.2828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Jain S.S., Steele J.M., Fonseca B., Huang S., Shah S., Maskatia S.A., et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021;148(5) doi: 10.1542/peds.2021-053427. [DOI] [PubMed] [Google Scholar]
  • 48.Truong D.T., Dionne A., Muniz J.C., McHugh K.E., Portman M.A., Lambert L.M., et al. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation. 2022;145(5):345–356. doi: 10.1161/CIRCULATIONAHA.121.056583. [DOI] [PubMed] [Google Scholar]
  • 49.Law Y.M., Lal A.K., Chen S., Čiháková D., Cooper L.T., Jr., Deshpande S., et al. Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association. Circulation. 2021;144(6):e123–e135. doi: 10.1161/CIR.0000000000001001. [DOI] [PubMed] [Google Scholar]
  • 50.Aquaro G.D., Perfetti M., Camastra G., Monti L., Dellegrottaglie S., Moro C., et al. Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY Study. J Am Coll Cardiol. 2017;70(16):1977–1987. doi: 10.1016/j.jacc.2017.08.044. [DOI] [PubMed] [Google Scholar]
  • 51.Gräni C., Eichhorn C., Bière L., Murthy V.L., Agarwal V., Kaneko K., et al. Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol. 2017;70(16):1964–1976. doi: 10.1016/j.jacc.2017.08.050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Greulich S., Seitz A., Müller K.A.L., Grün S., Ong P., Ebadi N., et al. Predictors of mortality in patients with biopsy-proven viral myocarditis: 10-Year outcome data. J Am Heart Assoc. 2020;9(16) doi: 10.1161/JAHA.119.015351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Eichhorn C., Greulich S., Bucciarelli-Ducci C., Sznitman R., Kwong R.Y., Gräni C. Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis. JACC Cardiovasc Imaging. 2022;15(7):1325–1338. doi: 10.1016/j.jcmg.2021.11.017. [DOI] [PubMed] [Google Scholar]
  • 54.Oster M.E., Shay D.K., Su J.R., Gee J., Creech C.B., Broder K.R., et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US From December 2020 to August 2021. JAMA. 2022;327(4):331–340. doi: 10.1001/jama.2021.24110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Oliver S. Summary and Work Group Interpretation: Extended intervals for mRNA COVID-19 vaccines 2022 [2/4/2022]. Available from: 〈https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2022–02-04/12-COVID-Oliver-508.pdf〉.
  • 56.Veronese G., Ammirati E., Cipriani M., Frigerio M. Fulminant myocarditis: characteristics, treatment, and outcomes. Anatol J Cardiol. 2018;19(4):279–286. doi: 10.14744/AnatolJCardiol.2017.8170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Amabile N., Fraisse A., Bouvenot J., Chetaille P., Ovaert C. Outcome of acute fulminant myocarditis in children. Heart. 2006;92(9):1269–1273. doi: 10.1136/hrt.2005.078402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Luetkens J.A., Homsi R., Dabir D., Kuetting D.L., Marx C., Doerner J., et al. Comprehensive cardiac magnetic resonance for short-term follow-up in acute myocarditis. J Am Heart Assoc. 2016;5(7) doi: 10.1161/JAHA.116.003603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Gräni C., Bière L., Eichhorn C., Kaneko K., Agarwal V., Aghayev A., et al. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Int J Cardiovasc Imaging. 2019;35(6):1067–1078. doi: 10.1007/s10554-019-01552-6. [DOI] [PubMed] [Google Scholar]
  • 60.Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330–2339. doi: 10.1016/j.jcmg.2020.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Bailey A.L., Dmytrenko O., Greenberg L., Bredemeyer A.L., Ma P., Liu J., et al. SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic Transl Sci. 2021;6(4):331–345. doi: 10.1016/j.jacbts.2021.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Chen Y., Sun Z., Xu L., Liu J., Li Y., Zhang N., et al. Diagnostic and prognostic value of cardiac magnetic resonance strain in suspected myocarditis with preserved LV-EF: a comparison between patients with negative and positive late gadolinium enhancement findings. J Magn Reson Imaging. 2022;55(4):1109–1119. doi: 10.1002/jmri.27873. [DOI] [PubMed] [Google Scholar]
  • 63.Korosoglou G., Giusca S., Hofmann N.P., Patel A.R., Lapinskas T., Pieske B., et al. Strain-encoded magnetic resonance: a method for the assessment of myocardial deformation. ESC Heart Fail. 2019;6(4):584–602. doi: 10.1002/ehf2.12442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Peer S.M., Bhat P.S., Furtado A.D., Chikkatur R. Right ventricular outflow tract aneurysm with thrombus. Interact Cardiovasc Thorac Surg. 2012;14(4):488–490. doi: 10.1093/icvts/ivr151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Kaur R., Bhurtel D., Bielefeld M.R., Morales J.M., Durham L.A., 3rd Cryopreserved saphenous vein compared with PTFE graft for use as modified Blalock-Taussig or central whunt in cyanotic congenital heart disease. World J Pediatr Congenit Heart Surg. 2018;9(5):509–512. doi: 10.1177/2150135118776616. [DOI] [PubMed] [Google Scholar]
  • 66.Chowdhury U.K., Airan B., Kothari S.S., Talwar S., Saxena A., Singh R., et al. Specific issues after extracardiac fontan operation: ventricular function, growth potential, arrhythmia, and thromboembolism. Ann Thorac Surg. 2005;80(2):665–672. doi: 10.1016/j.athoracsur.2005.02.024. [DOI] [PubMed] [Google Scholar]
  • 67.Bates O., Semple T., Krupickova S., Bautista-Rodriguez C. Case report of a Gore-Tex TCPC conduit dissection causing severe stenosis. Eur Heart J Case Rep. 2021;5(11) doi: 10.1093/ehjcr/ytab377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Elsayed A., Gilbert K., Scadeng M., Cowan B.R., Pushparajah K., Young A.A. Four-dimensional flow cardiovascular magnetic resonance in tetralogy of Fallot: a systematic review. J Cardiovasc Magn Reson. 2021;23(1) doi: 10.1186/s12968-021-00745-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Loke Y.H., Capuano F., Cleveland V., Mandell J.G., Balaras E., Olivieri L.J. Moving beyond size: vorticity and energy loss are correlated with right ventricular dysfunction and exercise intolerance in repaired Tetralogy of Fallot. J Cardiovasc Magn Reson. 2021;23(1) doi: 10.1186/s12968-021-00789-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hirtler D., Garcia J., Barker A.J., Geiger J. Assessment of intracardiac flow and vorticity in the right heart of patients after repair of tetralogy of Fallot by flow-sensitive 4D MRI. Eur Radiol. 2016;26(10):3598–3607. doi: 10.1007/s00330-015-4186-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Zhao X., Hu L., Leng S., Tan R.S., Chai P., Bryant J.A., et al. Ventricular flow analysis and its association with exertional capacity in repaired tetralogy of Fallot: 4D flow cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2022;24(1) doi: 10.1186/s12968-021-00832-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Egbe A.C., Miranda W.R., Pellikka P.A., DeSimone C.V., Connolly H.M. Prevalence and prognostic implications of left ventricular systolic dysfunction in adults with congenital heart disease. J Am Coll Cardiol. 2022;79(14):1356–1365. doi: 10.1016/j.jacc.2022.01.040. [DOI] [PubMed] [Google Scholar]
  • 73.Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011;13(1) doi: 10.1186/1532-429X-13-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Ghonim S., Gatzoulis M.A., Ernst S., Li W., Moon J.C., Smith G.C., et al. Predicting survival in repaired Tetralogy of Fallot: a lesion-specific and personalized approach. JACC Cardiovasc Imaging. 2022;15(2):257–268. doi: 10.1016/j.jcmg.2021.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Antonov N.K., Ruzal-Shapiro C.B., Morel K.D., Millar W.S., Kashyap S., Lauren C.T., et al. Feed and wrap MRI technique in Iifants. Clin Pediatr ((Phila)) 2017;56(12):1095–1103. doi: 10.1177/0009922816677806. [DOI] [PubMed] [Google Scholar]
  • 76.Patel C.R., Judge N.E., Muise K.L., Levine M.M. Prenatal myocardial infarction suspected by fetal echocardiography. J Am Soc Echocardiogr. 1996;9(5):721–723. doi: 10.1016/s0894-7317(96)90071-1. [DOI] [PubMed] [Google Scholar]
  • 77.Fratz S., Chung T., Greil G.F., Samyn M.M., Taylor A.M., Valsangiacomo Buechel E.R., et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15(1) doi: 10.1186/1532-429X-15-51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Bailliard F., Hughes M.L., Taylor A.M. Introduction to cardiac imaging in infants and children: Techniques, potential, and role in the imaging work-up of various cardiac malformations and other pediatric heart conditions. Eur J Radiol. 2008;68(2):191–198. doi: 10.1016/j.ejrad.2008.05.016. [DOI] [PubMed] [Google Scholar]
  • 79.Dalal D., Tandri H., Judge D.P., Amat N., Macedo R., Jain R., et al. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol. 2009;53(15):1289–1299. doi: 10.1016/j.jacc.2008.12.045. [DOI] [PubMed] [Google Scholar]
  • 80.Ochoa J.P., Sabater-Molina M., García-Pinilla J.M., Mogensen J., Restrepo-Córdoba A., Palomino-Doza J., et al. Formin homology 2 domain containing 3 (FHOD3) is a genetic basis for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2018;72(20):2457–2467. doi: 10.1016/j.jacc.2018.10.001. [DOI] [PubMed] [Google Scholar]
  • 81.Marcus F.I., McKenna W.J., Sherrill D., Basso C., Bauce B., Bluemke D.A., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806–814. doi: 10.1093/eurheartj/ehq025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Christensen A.H., Benn M., Bundgaard H., Tybjaerg-Hansen A., Haunso S., Svendsen J.H. Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy. J Med Genet. 2010;47(11):736–744. doi: 10.1136/jmg.2010.077891. [DOI] [PubMed] [Google Scholar]
  • 83.Borgquist R., Haugaa K.H., Gilljam T., Bundgaard H., Hansen J., Eschen O., et al. The diagnostic performance of imaging methods in ARVC using the 2010 Task Force criteria. Eur Heart J Cardiovasc Imaging. 2014;15(11):1219–1225. doi: 10.1093/ehjci/jeu109. [DOI] [PubMed] [Google Scholar]
  • 84.Haugaa K.H., Basso C., Badano L.P., Bucciarelli-Ducci C., Cardim N., Gaemperli O., et al. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy-an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18(3):237–253. doi: 10.1093/ehjci/jew229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Weinsaft J.W., Kim R.J., Ross M., Krauser D., Manoushagian S., LaBounty T.M., et al. Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging. 2009;2(8):969–979. doi: 10.1016/j.jcmg.2009.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Ezzeddine F.M., Giudicessi J.R., Maleszewski J.J., Lin P.T., Borlaug B.A., Geske J.B. Unmasking hydroxychloroquine cardiotoxicity in a patient with heart failure and chronotropic incompetence. JACC Case Rep. 2021;3(7):997–1001. doi: 10.1016/j.jaccas.2021.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Gupta R., Meghrajani V., Desai R., Gupta N. Primary malignant cardiac tumors: a rare disease with an adventurous journey. J Am Heart Assoc. 2020;9(10) doi: 10.1161/JAHA.120.016032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Antwi-Amoabeng D., Meghji Z., Thakkar S., Ulanja M.B., Taha M., Adalja D., et al. Survival differences in men and women with primary malignant cardiac tumor: an analysis using the surveillance, epidemiology and end results (SEER) database From 1973 to 2015. J Am Heart Assoc. 2020;9(10) doi: 10.1161/JAHA.119.014846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Orlandi A., Ferlosio A., Roselli M., Chiariello L., Spagnoli L.G. Cardiac sarcomas: an update. J Thorac Oncol. 2010;5(9):1483–1489. doi: 10.1097/JTO.0b013e3181e59a91. [DOI] [PubMed] [Google Scholar]
  • 90.Okamoto K., Kato S., Katsuki S., Wada Y., Toyozumi Y., Morimatsu M., et al. Malignant fibrous histiocytoma of the heart: case report and review of 46 cases in the literature. Intern Med. 2001;40(12):1222–1226. doi: 10.2169/internalmedicine.40.1222. [DOI] [PubMed] [Google Scholar]
  • 91.Truong P.T., Jones S.O., Martens B., Alexander C., Paquette M., Joe H., et al. Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience. Ann Surg Oncol. 2009;16(12):3358–3365. doi: 10.1245/s10434-009-0734-8. [DOI] [PubMed] [Google Scholar]
  • 92.Randhawa J.S., Budd G.T., Randhawa M., Ahluwalia M., Jia X., Daw H., et al. Primary cardiac sarcoma: 25-Year Cleveland Clinic experience. Am J Clin Oncol. 2016;39(6):593–599. doi: 10.1097/COC.0000000000000106. [DOI] [PubMed] [Google Scholar]
  • 93.Siontis B.L., Zhao L., Leja M., McHugh J.B., Shango M.M., Baker L.H., et al. Primary cardiac sarcoma: a rare, aggressive malignancy with a high propensity for brain metastases. Sarcoma. 2019;2019 doi: 10.1155/2019/1960593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Ramlawi B., Al-Jabbari O., Blau L.N., Davies M.G., Bruckner B.A., Blackmon S.H., et al. Autotransplantation for the resection of complex left heart tumors. Ann Thorac Surg. 2014;98(3):863–868. doi: 10.1016/j.athoracsur.2014.04.125. [DOI] [PubMed] [Google Scholar]
  • 95.Gabelman C., Al-Sadir J., Lamberti J., Fozzard H.A., Laufer E., Replogle R.L., et al. Surgical treatment of recurrent primary malignant tumor of the left atrium. J Thorac Cardiovasc Surg. 1979;77(6):914–921. [PubMed] [Google Scholar]
  • 96.Okita Y., Miki S., Ueda Y., Tahata T., Sakai T., Matsuyama K. Recurrent malignant fibrous histiocytoma of the left atrium with extracardiac extension. Am Heart J. 1994;127(6):1624–1628. doi: 10.1016/0002-8703(94)90397-2. [DOI] [PubMed] [Google Scholar]
  • 97.Sun J., Liu R., Wang W., Sun M., Wang L., Wang X., et al. Primary cardiac malignant fibrous histiocytoma with vulvar metastases: a case report. Oncol Lett. 2015;10(5):3153–3156. doi: 10.3892/ol.2015.3683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Motwani M., Kidambi A., Herzog B.A., Uddin A., Greenwood J.P., Plein S. MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology. 2013;268(1):26–43. doi: 10.1148/radiol.13121239. [DOI] [PubMed] [Google Scholar]
  • 99.Munin M.A., Goerner M.S., Raggio I., Wisner J., Tettamanzi A., Godia J., et al. A rare cause of dyspnea: undifferentiated pleomorphic sarcoma in the left atrium. Cardiol Res. 2017;8(5):241–245. doi: 10.14740/cr590w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C., Bueno H., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2018;39(2):119–177. doi: 10.1093/eurheartj/ehx393. [DOI] [PubMed] [Google Scholar]
  • 101.Redfors B., Råmunddal T., Shao Y., Omerovic E. Takotsubo triggered by acute myocardial infarction: a common but overlooked syndrome? J Geriatr Cardiol. 2014;11(2):171–173. doi: 10.3969/j.issn.1671-5411.2014.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Plácido R., Cunha Lopes B., Almeida A.G., Rochitte C.E. The role of cardiovascular magnetic resonance in takotsubo syndrome. J Cardiovasc Magn Reson. 2016;18(1) doi: 10.1186/s12968-016-0279-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Kim R.J., Wu E., Rafael A., Chen E.L., Parker M.A., Simonetti O., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–1453. doi: 10.1056/NEJM200011163432003. [DOI] [PubMed] [Google Scholar]
  • 104.Leiner T., Bogaert J., Friedrich M.G., Mohiaddin R., Muthurangu V., Myerson S., et al. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2020;22(1) doi: 10.1186/s12968-020-00682-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895–e1032. doi: 10.1161/CIR.0000000000001063. [DOI] [PubMed] [Google Scholar]
  • 106.McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368. [DOI] [PubMed] [Google Scholar]
  • 107.Hayes S.N., Kim E.S.H., Saw J., Adlam D., Arslanian-Engoren C., Economy K.E., et al. Spontaneous coronary artery dissection: current state of the science: a Scientific Statement From the American Heart Association. Circulation. 2018;137(19):e523–e557. doi: 10.1161/CIR.0000000000000564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Tan N.Y., Hayes S.N., Young P.M., Gulati R., Tweet M.S. Usefulness of cardiac magnetic resonance imaging in patients with acute spontaneous coronary artery dissection. Am J Cardiol. 2018;122(10):1624–1629. doi: 10.1016/j.amjcard.2018.07.043. [DOI] [PubMed] [Google Scholar]
  • 109.Al-Hussaini A., Abdelaty A., Gulsin G.S., Arnold J.R., Garcia-Guimaraes M., Premawardhana D., et al. Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management. Eur Heart J. 2020;41(23):2197–2205. doi: 10.1093/eurheartj/ehz895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Braunwald E., Kloner R.A. Myocardial reperfusion: a double-edged sword? J Clin Invest. 1985;76(5):1713–1719. doi: 10.1172/JCI112160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Ibáñez B., Heusch G., Ovize M., Van de Werf F. Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015;65(14):1454–1471. doi: 10.1016/j.jacc.2015.02.032. [DOI] [PubMed] [Google Scholar]
  • 112.Ibanez B., Aletras A.H., Arai A.E., Arheden H., Bax J., Berry C., et al. Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;74(2):238–256. doi: 10.1016/j.jacc.2019.05.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Chandrasekhar J., Thakkar J., Starovoytov A., Mayo J., Saw J. Characteristics of spontaneous coronary artery dissection on cardiac magnetic resonance imaging. Cardiovasc Diagn Ther. 2020;10(3):636–638. doi: 10.21037/cdt.2020.02.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Kosecik M., Karaoglanoglu M., Yamak B. Pericardial hydatid cyst presenting with cardiac tamponade. Can J Cardiol. 2006;22(2):145–147. doi: 10.1016/s0828-282x(06)70254-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Mathur P.N., S P., Joshi C.P., Kumawat J.L. Hydatid disease-still endemic in the southern region of state of Rajasthan, India: a clinical study carried out in tertiary care hospital. International Surgery Journal. 2016;3(4):1802–1805. [Google Scholar]
  • 116.WHO. PAIR: Puncture, Aspiration, Injection, Re-aspiration an option for the treatment of cystic echinococcosis 2001 [Available from: 〈http://apps.who.int/iris/bitstream/handle/10665/67207/WHO_CDS_CSR_APH_2001.6.pdf?sequence=1〉.
  • 117.Firouzi A., Neshati Pir Borj M., Alizadeh Ghavidel A. Cardiac hydatid Cyst: a rare presentation of echinococcal infection. J Cardiovasc Thorac Res. 2019;11(1):75–77. doi: 10.15171/jcvtr.2019.13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Movie 1

Case 1 Movie 1. Balanced steady-state free precession (bSSFP) cine coronal plane. A large aneurysm of LAD (green arrow) coronary artery next to the pulmonary artery is present. The giant aneurysm of the LAD has a comparable diameter to adjacent pulmonary artery.

Download video file (64.3KB, mp4)
Movie 2

Case 1 Movie 2. Short axis bSSFP cine at the base. The giant aneurysm of the LAD can be seen in the interventricular groove (red arrow).

Download video file (65.1KB, mp4)
Movie 3

Case 1 Movie 3. Shaded surface display volume rendering creating a 3D visual illustration of CT volumetric data of the heart. Multiple fusiform aneurysms of coronary arteries are depicted.

Download video file (1.5MB, mp4)
Movie 4

Case 2 Movie 1. Cine bSSFP short axis stack. There are multiple intramyocardial masses in the LV and RVs.

Download video file (142.7KB, mp4)
Movie 5

Case 2 Movie 2. Four chamber (A) and mid short axis (B) rest perfusion imaging. There is brisk uptake of contrast of the myocardial masses on first pass perfusion.

Download video file (498.9KB, mp4)
Movie 6

Case 3 Movie 1. Apical five chamber TTE view. There is a large, thin-walled, hypocontractile left sided chamber, concerning for a possible giant LA appendage aneurysm.

Download video file (1.1MB, mp4)
Movie 7

Case 3 Movie 2. Cine bSSFP four chamber view. There is a widely patent left atrioventricular junction with dephasing flow artifact present with absent mitral valve leaflets, chordae and papillary muscles.

Download video file (22.9KB, mp4)
Movie 8

Case 3 Movie 3. Cine bSSFP short axis view. There is severe LV dilation with extremely thin anterior, inferior, and lateral walls. The LV moves in synchrony with the RV but with moderate global hypokinesia.

Download video file (37.3KB, mp4)
Movie 9

Case 4 Movie 1. Parasternal short axis color Doppler TTE. There is color flow in and out of the LV diverticulum.

Download video file (991.5KB, mp4)
Movie 10

Case 4 Movie 2. Two chamber (A), four chamber (B), and mid short axis (C) cine bSSFP. There is a LV diverticulum of the inferior basal to mid walls.

Download video file (80.4KB, mp4)
Movie 11

Case 4 Movie 3. Four month follow-up mid short axis (A) and two chamber (B) cine bSSFP. The LV diverticulum of the basal to mid inferior wall is unchanged.

Download video file (94.7KB, mp4)
Movie 12

Case 5 Movie 1. Cine short axis stack bSSFP. There is normal LV and RV chamber size and global systolic function with no regional wall motion abnormalities present.

Download video file (253.5KB, mp4)
Movie 13

Case 6 Movie 1. Parasternal short axis TTE view. There is severe LV systolic dysfunction and moderate pericardial effusion present.

Download video file (700.2KB, mp4)
Movie 14

Case 6 Movie 2. Two chamber (A) and four chamber (B) cine bSSFP views. There is normal bi-ventricular size and systolic function with mild mitral regurgitation and no significant residual pericardial effusion.

Download video file (142.2KB, mp4)
Movie 15

Case 6 Movie 3. Four chamber strain encoded imaging measuring circumferential strain. The patient’s LV global longitudinal (GLS) and global circumferential strain (GCS) were both normal at −18.3% and −19%, respectively (institutional control data with normal values of LV GLS < −17% and LV GCS < −18%).

Download video file (161.6KB, mp4)
Movie 16

Case 8 Movie 1. Short-axis bSSFP cine from base to apex. Normal LV and RV size and global systolic function present. There was diminished systolic thickening of the basal septal segments.

Download video file (437.2KB, mp4)
Movie 17

Case 9 Movie 1. Four chamber TTE without (A) and with (B) contrast enhancement. There is asymmetric severe LV wall hypertrophy, akinesia of apical segment, and a small hypointense mass in the apex.

Download video file (461.1KB, mp4)
Movie 18

Case 9 Movie 2. Cine bSSFP short axis stack. There is asymmetrically increased LV wall thickness (maximum diameter 21 mm) of basal to mid septal and anterior segments with LV apical aneurysm and probable thrombus. Small pericardial effusion is present.

Download video file (381.1KB, mp4)
Movie 19

Case 9 Movie 3. Cine bSSFP two chamber (A), three chamber (B), four chamber (C), and RV outflow tract (D) views. There is severe asymmetrical increased LV wall thickness (A-C) and systolic anterior motion of the anterior leaflet of the mitral valve with dynamic outflow tract obstruction (B). Mass seen in the LV apex likely representing a thrombus (A). Dyskinetic systolic bulging of a microaneurysm can be seen in the RV outflow tract free wall (B,D) and dyskinetic aneurysm in RV inferior wall (D). The RV is dilated with “accordion sign” in the sub-tricuspid “triangle of dysplasia” (C). Note that small outpouching of apical RV free wall is due to tethering by moderator band and is a normal variant that may be mistaken for regional wall motion abnormality (C).

Download video file (115.4KB, mp4)
Movie 20

Case 10 Movie 1. TTE parasternal short axis view. There is a large mass in the LA protruding through the mitral valve. A small hypoechoic area of necrosis is seen within the mass.

Download video file (2.1MB, mp4)
Movie 21

Case 10 Movie 2. TTE parasternal short axis view post-surgical resection of LA mass. There is a small area of irregularity in the posterior LA, which may represent post-surgical changes or residual mass.

Download video file (408KB, mp4)
Movie 22

Case 10 Movie 3. Brain magnetic resonance imaging sagittal view. There are two enhancing intracranial masses (arrows) due to metastasis.

Download video file (788KB, mp4)
Movie 23

Case 10 Movie 4. TTE in parasternal long axis (A), parasternal short axis (B), off-axis four chamber (C), and four chamber (D) views. There is a large mass in the LA that obstructs the mitral valve (MV). Color Doppler (C,D) images show evidence of flow acceleration due to MV obstruction.

Download video file (889.9KB, mp4)
Movie 24

Case 10 Movie 5. Cine bSSFP in four chamber stack, two chamber, and basal short axis sagittal views. There is recurrence of the large mass in the LA extending into the right pulmonary veins.

Download video file (1.5MB, mp4)
Movie 25

Case 10 Movie 6. Basal short axis first pass perfusion sequence. The LA mass appears avascular in this portion of the mass.

Download video file (200.5KB, mp4)
Movie 26

Case 10 Movie 7. Four chamber stack cine bSSFP images. There is a large LA mass prolapsing across the mitral valve.

Download video file (680.8KB, mp4)
Movie 27

Case 11 Movie 1. Cine bSSFP imaging in two chamber (A), three chamber (B), four chamber (C), and mid short-axis (D) orientations. There is akinesis/dyskinesis of all mid and distal LV segments with basal segments hyperkinetic. Bilateral pleural effusions (A-C) are present.

Download video file (252KB, mp4)
Movie 28

Case 11 Movie 2. Cine bSSFP images in two chamber (A), three chamber (B), four chamber (C), and mid short-axis (D) orientations. LV systolic function has normalized.

Download video file (167.1KB, mp4)
Movie 29

Case 12 Movie 1. Coronary angiogram in anteroposterior projection. There is an abrupt tapering of the obtuse marginal 1 branch of the left circumflex, concerning for spontaneous coronary artery dissection.

Download video file (1.1MB, mp4)
Movie 30

Case 12 Movie 2. TTE with contrast apical three chamber (A) and four chamber (B) views. There is hypokinesia of the mid to distal inferolateral and anterolateral walls.

Download video file (1.5MB, mp4)
Movie 31

Case 12 Movie 3. Cine bSSFP images in four chamber (A) and short axis stack (B). There is focal akinesia in the lateral apical LV wall.

Download video file (1.3MB, mp4)
Movie 32

Case 12 Movie 4. Apical short axis rest first pass perfusion. There is a sub-endocardial rest perfusion defect in the apical LV lateral wall.

Download video file (342.7KB, mp4)
Movie 33

Case 13 Movie 1. Four chamber cine bSSFP images. There is a large pericardial effusion, multiloculated cystic lesion along the lateral LV wall, extending posterior to the aortic root, ascending aorta, inferior to the main pulmonary artery and anterior to the LA appendage.

Download video file (185.5KB, mp4)
Movie 34

Case 13 Movie 2. Mid short axis cine bSSFP (A) and rest perfusion (B) slices. There is hypokinesia of the mid lateral LV wall with decreased perfusion.

Download video file (889.4KB, mp4)

Data Availability Statement

All data generated or analyzed during this study are included in this published article [and its supplementary information files].


Articles from Journal of Cardiovascular Magnetic Resonance are provided here courtesy of Elsevier

RESOURCES